Skip to main content
HPB : The Official Journal of the International Hepato Pancreato Biliary Association logoLink to HPB : The Official Journal of the International Hepato Pancreato Biliary Association
. 2006;8(4):264–286. doi: 10.1080/13651820500467358

Review of experimental animal models of acute pancreatitis

Kim Hue Su 1, Christine Cuthbertson 1, Christopher Christophi 1,
PMCID: PMC2023897  PMID: 18333137

Abstract

The underlying mechanisms involved in the pathogenesis of acute pancreatitis are ill understood. The mortality rate of this disease has not significantly improved over the past few decades. Current treatment options are limited, and predominantly aimed at supportive therapy. A key feature of severe acute pancreatitis is the presence of extensive tissue necrosis with both local and systemic manifestations of inflammatory response syndromes. A better understanding of the underlying pathophysiology of severe acute pancreatitis may lead to more targeted therapeutic options, potentially leading to improved survival. Animal models of acute pancreatitis are therefore an essential investigative tool for these aims to be achieved. This review discusses the suitability of recent non-invasive models of acute pancreatitis such as hormone-induced, alcohol-induced, immune-mediated, diet-induced, gene knockout and L-arginine; and invasive models including closed duodenal loop, antegrade pancreatic duct perfusion, biliopancreatic duct injection, combination of secretory hyperstimulation with minimal intraductal bile acid exposure, vascular-induced, ischaemia/reperfusion and duct ligation.

Keywords: Acute pancreatitis, animal models

Introduction

Acute pancreatitis has a relative frequency ranging from 5 to 80 cases per 100 000 population in the Western world. There are several aetiological factors, the majority being gallstones- or alcohol-related 1,2. The severity of clinical presentation varies from a mild, self-limiting form to severe disease complicated by sepsis and multi-organ failure. About 25% of patients with acute pancreatitis have severe disease, with a mortality rate approaching 30–40% 3. The precise underlying mechanisms of severe acute pancreatitis are unknown. The main features of this condition are pancreatic necrosis and associated sepsis, with both localized and systemic inflammatory response syndromes 4,5. Specific therapy aimed at the underlying pathophysiological pathways is largely experimental and so far ineffectual in human studies.

The pathophysiology event of experimental acute pancreatitis consists of the activation of pancreatic enzymes within acinar cells, the release of these activated enzymes in the interstitium, the autodigestion of the pancreas, and the release of activated pancreatic enzymes and other factors into the circulation that result in the development of multiple organ dysfunction 6,7,8,9. Currently, the factors that determine the ultimate severity of the acute pancreatitis remain uncertain 10,11,12,13,14,15.

Several concepts of the pathophysiology of acute experimental pancreatitis have emerged (see references/review in Frossard 16). One concept of the disease includes maintaining the stability between anti- and pro-inflammatory cytokines/chemokines 17,18. It has been shown that T lymphocytes, particularly, CD4+ T cells, are important in the development of tissue injury during acute pancreatitis in mice 19. Another concept of the pathophysiology of acute pancreatitis includes the fine balance between necrosis and apoptosis. It has been hypothesized that apoptosis might be a favourable response to acinar cell injury, suggesting that induction of apoptosis can effectively reduce the severity of acute pancreatitis 20,21,22 and may be beneficial in the clinical management of acute pancreatitis. An additional concept includes having a favourable ratio between reactive oxygen species and free radical scavengers. Animal models have been shown to exhibit rapid increases in the concentration of peroxidation products both in pancreatic tissue and serum, with peak changes during the first 6 h after acute pancreatitis induction 23,24,25,26,27. It has been suggested that reactive oxygen species play a pivotal role in signal transduction 28, and may cause alterations in cytoskeleton function 29. However, results of well-designed clinical studies have yet to prove the benefits of enzyme scavengers to individuals suffering from acute pancreatitis 30.

Experimental models of acute pancreatitis resembling the human situation are an integral tool to increase the understanding of the complex mechanisms and in devising therapeutic strategies for this disease. Several experimental models of severe acute pancreatitis have been produced. These models may be arbitrarily divided into invasive and non-invasive varieties according to the method of induction of acute pancreatitis.

An ideal model of acute pancreatitis should encompass several features. It should be easily reproducible, with the ability to vary the severity of acute pancreatitis in a standardized manner according to the experimental aims. The morphology and pathophysiology should resemble that of the human situation. This article assesses current models of acute pancreatitis with particular emphasis on their suitability as a research tool for the human disease.

Non-invasive models of acute pancreatitis

Several non-invasive models of experimental acute pancreatitis have been developed in an attempt to investigate the initiation, progression and treatment of this disease (Table I).

Table I. Summary of the advantages, disadvantages and clinical relevance of non-invasive experimental models of acute pancreatitis.

Model Advantages Disadvantages Clinical relevance References
Hormone-induced
  • Causes acute pancreatitis in a variety of animals, i.e. rats, mice, dogs and Syrian hamsters

  • Can induce acute pancreatitis by a number of injection routes, i.e. intravenous, subcutaneous or intraperitoneal; the preferred method is intravenous route

  • Allows accurate control of the infusion rate, thereby enabling control of the timing and severity of acute pancreatitis

  • Useful for studying cell biology, gut endocrine interactions such as secretin and CCK levels, pathogenesis of acute pancreatitis-related pulmonary pathology, systemic disease manifestation, and healing and regeneration of damaged tissue after the toxic substance has been discontinued

  • Relatively simple

  • Inexpensive to perform

  • Only mild acute pancreatitis develops

  • Negligible mortality

  • High variability in the course and severity of underlying acute pancreatitis and thus unsuitable for controlled studies

  • Pulmonary injury in rats resembles the early stages of the adult respiratory distress syndrome in human

  • Structural changes of acinar cells are similar to human acute pancreatitis

  • Specific changes to intracellular membrane systems of acinar cells resemble human acute pancreatitis

  • Simulates acute pancreatitis induced by Trinidadian scorpion toxin or anti-cholinesterase insecticide poisoning in humans

30,31,32,33,34
Alcohol-induced
  • Useful for studying changes to pancreatic blood flow and the microcirculation, the effect on pancreatic acinar damage by alcohol-related free oxygen radical generation, metabolites and the effect on pancreatic regeneration

  • Has been used in several animal models, i.e. rats, cats and dogs

  • Various route of ethanol administration, i.e. intravenous, oral and direct intragastric instillation

  • Relatively simple

  • Cheap to perform

  • Selectively lessens pancreatic blood flow and microcirculation

  • Gene knockout animals may be used to determine the effect of genetic factors on the development of acute alcohol-related pancreatic injury

  • Animal models of pancreatitis, induced by acute ethanol application alone, have been difficult to produce significant pancreatic damage, and thus require prior sensitization with other agents

  • Lack of reproducibility

  • Lack of correlation with the clinical situation

50,53,56,57,60,61,62,63,64,65,66
Immune-mediated
  • Possible application in the field of drug- or toxin-induced acute pancreatitis

  • Challenging to set up in laboratory

  • Time-consuming

  • Limited reproducibility

  • Costly

  • High early mortality rate, difficult for studying pathogenesis or treatment options

  • Development of secondary diabetes due to the involvement of the islets of Langerhans

  • Clinical relevance uncertain

72,73,76,77,78,79
Diet-induced
  • Simplest method to study acute haemorrhagic pancreatitis

  • Well-established

  • Cheap

  • High reproducibility

  • No surgical procedure involved

  • Mortality rate can be controlled at any desired level between 0% and 100% by modifying feeding protocol

  • Useful for studying the pathophysiology for acute pancreas and potential experimental treatment by measuring survival, biochemistry, histology, changes in haematocrit, pH and blood gases

  • Produces haemorrhage and necrosis with a lethal course

  • Inflammatory lesions are homogeneously distributed

  • Species-specific; may only be used in mice, whose small size causes technical difficulties

  • Sex-specific; female mice

  • Variable onset of acute pancreatitis

  • Requires careful monitoring to ensure that intake of the CDE diet is the same in different experimental groups

  • Produces severe necrotizing that approximates human pancreatitis

  • Gross and histological appearance of the pancreatic and peripancreatic inflammation, and clinical and biochemical course of diet-induced pancreatitis, resemble the human disease

  • Ascites, acidosis, hypoxia and hypovolaemia similar to human acute pancreatitis

82,84
Gene knockout
  • Useful for studying the function or effect of a specific gene of interest

  • Avoids the use of pharmacological manipulations that often cause side effects

  • Time-consuming

  • Expensive

  • Complex

  • Altering the specific gene from the time of its conception could mean that other protein expressions may result to compensate for the mutation

  • Mutation may stimulate unforeseen phenotypic changes if a gene is expressed in different tissues

  • Expression of two genes may overlap and the alteration in a single gene might mask an abnormal phenotype

Extrapolation of experimental data to humans is difficult 90,91,92,93,94,95,96,97,98,99,101,102,103,104,105,106,107
L-arginine (Arg)
  • High reproducibility

  • Ability to achieve selective dose-dependent pancreatic acinar cell necrosis

  • Suitable for investigating the early and late phases of acute pancreatitis

  • Useful for investigating the insulo-acinar axis, extrapancreatic organ damage and its mechanisms

  • Long-term administration of Arg produces chronic pancreatitis induction

  • In a clinical situation, the circulatory, pulmonary, renal and hepatic failure (multi-organ failure) significantly affects the morbidity and mortality of acute pancreatitis

189,199,200,201,202,203

Hormone-induced model

Caerulein, a cholecystokinin-pancreozymin analogue, has been used to successfully cause acute pancreatitis in rats 31,32, mice 33, dogs 34, and Syrian hamsters 35. Acute pancreatitis may be induced by intravenous, subcutaneous or intraperitoneal injection routes. Using this method, proteolytic enzyme secretion may be increased to levels that cause pancreatic acinar autolysis 36. The intravenous route is the preferred method. It allows accurate control of the infusion rate, and thus control of the timing and severity of the acute pancreatitis 31,34,37. One hour after infusion of caerulein, progressive interstitial oedema develops and reaches a maximum after 12 h. The dose of caerulein may be gradually increased. Pancreatic enzymes in the blood circulation, pancreatic inflammation, acinar cell necrosis and fat necrosis can be observed following a two-fold increase in the caerulein dose 31,38,39,40,41.

Acute caerulein pancreatitis has been shown to be particularly effective for investigating the pathogenesis of pancreatitis-related pulmonary pathology 42,43. The appearance of the pulmonary injury in rats using this model resembles the early stages of the adult respiratory distress syndrome in humans. The structural changes of acinar cells observed in human acute pancreatitis exhibit many similar characteristics to caerulein-induced acute pancreatitis in rats 44,45,46. In particular, specific changes to intracellular membrane systems of acinar cells were similar in both human and caerulein-induced acute pancreatitis. This model appears to simulate the pathophysiology of acute pancreatitis induced by Trinidadian scorpion toxin 47 or anti-cholinesterase insecticide 48 poisoning in humans. Both these agents have been employed to induce experimental acute pancreatitis in dogs 49,50.

The advantages of the hormone-induced model are that it is relatively simple and inexpensive to perform. This model has been frequently used to study the cell biology and pathophysiological events in acute pancreatitis. It is also useful for studying systemic disease manifestation. Apart from investigation of the pulmonary aspects of acute pancreatitis, it has also proved particularly useful in elucidating information on gut endocrine interactions such as secretin and cholecystokinin (CCK) levels. Another advantage of this model is that it allows investigation of healing and regeneration of damaged tissue after the toxic substance has been discontinued.

This model has two major disadvantages. Despite infusion of maximum doses of caerulein, only mild acute pancreatitis develops, with negligible mortality. In addition, the course and severity of the underlying acute pancreatitis are highly variable and thus relatively unsuitable for controlled studies.

Alcohol-induced model

The acute effects of ethanol on the pancreas have been investigated in several animal studies in order to investigate the underlying pathophysiological mechanisms leading to alcohol-induced acute pancreatitis. Animal models of acute pancreatitis, induced by acute ethanol application alone, have been difficult to produce 51,52 and require prior sensitization with other agents 53,54,55,56 to allow significant pancreatic damage to occur. Developing an experimental model requiring direct ethanol installation via the pancreatic duct is not relevant in a clinical situation. This is because installation of any agent corresponding to concentration and pressure would result in pancreatic injury. Thus, acute ethanol administration has been combined with other substances to study the pathophysiological events. These models have proved particularly useful to study specific alcohol-induced effects such as changes to pancreatic blood flow and the microcirculation, the effect on pancreatic acinar damage by alcohol-related free oxygen radical generation, metabolites and the effect on pancreatic regeneration (see references/review in Schneider et al. 57).

Several animal models have been used including rats, cats and dogs. The routes of ethanol administration include intravenous, oral and direct intragastric instillation. The morphology of the acute pancreatitis varies according to the animal model, the dose of ethanol administration and the presensitization agents used. It has recently been established that ethanol may lead to the onset of acute pancreatitis via its effect on intrapancreatic digestive enzyme activation, by either directly sensitizing acinar cells to pathologic stimuli 58 or stimulating the release of a secretagogue, CCK, from duodenal I cells 59. Although the exact role of the various digestive enzymes in initiating pancreatitis remains controversial, it has been established that ethanol can directly interfere with the processes that are involved in digestive zymogen activation (see references/review in Lerch et al. 60).

The model by Siech et al. 51 combines oral ethanol ingestion and the use of low doses of CCK and secretin to simultaneously stimulate the glands of female Sprague-Dawley rats. Histological changes include evidence of pancreatic duct obstruction, interlobular oedema, cellular inflammatory infiltrates and perilobular fat and parenchymal necrosis 51. Letko et al. 54 used the same model to test the various modes of ethanol administration and found that it did not influence the development of acute pancreatitis. A number of other studies have found that ethanol can sensitize acinar cells to CCK-induced procarboxypeptidase A1 processing in vitro and can sensitize to various forms of acute pancreatitis in vivo61,62,63,64. In this way, ethanol is thought to increase stimulation-dependent induction of acute pancreatitis, and thus may be important in ethanol toxicity in the pancreas.

In a study by Wedgwood et al. 65, a cat model of acute pancreatitis was used to study the direct effects of oral ethanol (ethanol 20% v/v in milk, 10 ml/kg every 8 h for 48 h) on the permeability of the pancreatic duct. After the duct was cannulated and perfused with activated enzyme solution, the ethanol-fed cats were induced with acute oedematous acute pancreatitis and the control cats remained unchanged. In a separate study, Friedman et al. 66 studied the effect of ethanol application on pancreatic blood flow in dogs. They found a reduction in pancreatic blood flow in the dogs after intravenous infusion of an ethanol dose that would equate to mild to moderate alcohol intoxication in human. These pancreatic blood flow alterations were not detected at comparable blood ethanol concentrations in pentobarbital-anaesthetized dogs 66.

In another new study, Lu et al. 67 found that trypsinogen and chymotrypsinogen showed distinct patterns of activation in response to supraphysiological concentrations of the CCK analogue caerulein. They also noted that ethanol and other alcohols sensitized the acinar cell to caerulein-induced trypsin and chymotrypsinogen activation, and that other short-chain n-aliphatic alcohols (methanol, propanol, and butanol) advanced the effects of caerulein on the acinar cell. However, when only ethanol was used, neither acute pancreatitis nor zymogen activation was induced in experimental models of acute pancreatitis. Thus, these studies indicate that CCK receptor activation can stimulate various patterns of zymogen activation in pancreatic acinar cells and the extent of activation can be increased by a distinct set of short-chain alcohols. It is still not known, however, whether ethanol and other alcohols mediate these effects by interfering with acinar cell signalling pathways or by affecting acinar cell membrane fluidity.

In 1995, Weber et al. 68 investigated the activity of oxygen radical generating xanthine oxidase in the pancreas of rats treated with either dibutyltin dichloride/ethanol (6 mg/kg/13.7 mg/kg, i.v.), ethanol alone (13.7 mmol/kg, i.v.), or isotonic saline as control. The authors measured the activities of oxygen radical scavengers, superoxide dismutase and glutathione peroxidase, and determined the levels of the lipid peroxidation marker, malondialdehyde. Weber et al. 68 found that tissue imbalance between oxidants and antioxidants may be important in the pathogenesis of dibutyltin dichloride/ethanol-induced acute interstitial pancreatitis, and that although ethanol increases oxygen radical generation, more damage is needed for acute pancreatitis to develop.

Werner et al. 69 studied the acute effects of ethanol on the pancreas by the infusion of non-oxidative products of ethanol metabolism such as fatty acid ethyl esters in Sprague-Dawley rats. They observed increases in pancreatic oedema formation, pancreatic trypsinogen activation and vacuolization of acinar cells. The authors also concluded that fatty acid ethyl esters at concentrations found in human plasma produce an acute pancreatitis-like injury in rats, providing direct evidence that fatty acid ethyl esters can produce organ-specific toxicity. Fatty acid ethyl esters may be important in acute alcohol-induced damage to the pancreas.

Existing alcohol-induced models are relatively simple and cheap to perform. Acute ethanol administration selectively lessened pancreatic blood flow and microcirculation, suggesting that the effect of alcohol might increase ischaemia damage during the evolvement of acute pancreatitis with or without underlying chronic disease. Another advantage of this model is that it allows alcohol to directly damage the pancreas by the influence of toxic ethanol metabolites, and perhaps by limitations of pancreatic regeneration. Reproducibility, however, has not been successfully achieved. Furthermore, there is a lack of correlation with the clinical setting. Gene knockout animals may be used to determine the influence of genetic factors on the development of acute alcohol-related pancreatic injury.

Gene knockout model

Gene knockout models have been developed to further understand how specific genes might regulate acute pancreatitis. The method requires precise removal of the specific gene of interest and replacing it with a mutant gene that is inactive, altered or irrelevant. Rinderknecht 18 first commented that the severity of the local disease and the systemic complications may increase due to the inappropriate activation of the immune system. In recent years, there has been accumulating evidence demonstrating that synthesis and release of proinflammatory cytokines and chemokines influence the local injury and the systemic dispersion of the inflammation. Gene knockout models may be used to examine the effects of cytokine and chemokine mediators as well as their receptors in the pancreas and distant organs. It has been shown that the deletion or alteration of a single gene does not entirely prevent injury in the pancreas or remote organ. This is indicative of many redundancies of ligands and receptors characteristic of the cytokine and chemokine families. Gene knockout models have been used to determine the function of several specific targeted genes such as interleukin (IL)-1 and tumour necrosis factor-α 70,71,72,73, IL-6 74, IL-10 75, chemoattractant cytokine receptor-1 76, neurokinin-1 receptor 77,78, intercellular adhesion molecule-1 (ICAM-1) 79,80,81, metallothionein-1 82, cathepsin B 83, mouse α2-macroglobulin and murinoglobulin 84, complement factor C5a 85,86, granulocyte-macrophage colony-stimulating factor 20 and phospholipase A287.

Knockout models are increasingly used to examine the cause and course of acute pancreatitis. The advantage of the gene knockout models is that by deleting the specific gene of interest, its function or effect can be revealed or clarified. Furthermore, the use of pharmacological manipulations which often cause side effects can be avoided. This allows investigation of the effects of a specific cytokine to be carried out. In general, the gene knockout model is time-consuming, expensive and complex to perform. Another disadvantage is that the specific gene alteration from the time of its conception could mean that other protein expressions may result to compensate for the mutation. In addition, the mutation may stimulate unforeseen phenotypic changes if a gene is expressed in different tissues. On the other hand, the expression of two genes may overlap and the alteration in a single gene might mask an abnormal phenotype. Any extrapolation of experimental data from gene knockout models to humans is therefore difficult.

Immune-mediated model

Immune-mediated models of acute pancreatitis may be induced by both non-invasive and invasive means, usually involving pancreatic intraductal infusion of a variety of agents. Thal and Brackney 88 first described an immunologically induced acute pancreatitis model by infusing bacterial toxin of Escherichia coli and meningococci into the pancreatic duct of goats and rabbits. This produced a local Shwartzman reaction in the pancreas. The authors administered the same toxin 24 h later which led to acute haemorrhagic and necrotizing pancreatitis. None of the animals survived within 4–24 h after the second doses 88. In a separate study, Thal 89 reported other varieties of acute pancreatitis associated with an Arthus phenomenon which involved sensitizing rabbits by intravenous or subcutaneous administration of ovalbumin. The degree of pancreatitis ranged from acute non-fatal interstitial pancreatitis to severe pancreatic necrosis. Thal 89 observed that both types of experimental acute pancreatitis resembled the interstitial and necrotic forms seen in humans. The morphological studies of these models have suggested that vascular factors induced by both the Shwartzman and Arthus reactions have been identified as playing a major role in the pathophysiologic pathways of this model of experimental acute pancreatitis.

Acute pancreatitis has also been induced by an intraperitoneal injection of foreign serum in mice. This model is characterized by acinar cell necrosis, fat necrosis, hyperamylasaemia and inflammatory response syndromes 90,91. Nevalainen 92 described another model of acute necrotizing pancreatitis by injecting fresh rabbit serum either intraperitoneally or into the rat pancreatic duct. Features of early membrane impairment resulting in osmotic damage, death and necrosis of affected acinar cells were observed 92. Other immunology-based models have been documented 93,94. These include intraductal administration of anti-acinar cell antiserum to rats causing a progressive inflammatory process leading to severe necrosis within 16 h of induction. A spontaneous model of autoimmune acute pancreatitis in the MRL/MP strain of mice has also been described 95. Histological features include severe inflammatory changes and extensive acinar tissue necrosis, which appear to be mediated by cellular autoimmune mechanisms, in particular, CD4+ cells 95. Acute pancreatitis in this model may be induced in genetically different animals by the transfer of spleen cells from the affected animal 95.

Immune-mediated models are not recommended for the study of acute pancreatitis. These models are challenging to set up in the laboratory, time-consuming, have limited reproducibility, are costly, and the clinical relevance is unclear 96. The high early mortality rate makes investigation of pathogenesis or treatment options difficult to assess. Another major disadvantage of this model is the development of secondary diabetes due to the involvement of the islets of Langerhans 97. One possible application of this model is in the field of drug- or toxin-induced acute pancreatitis 97.

Diet-induced model

Lombardi et al. 98 developed a diet-induced model of acute pancreatitis by inducing severe acute necrotizing pancreatitis in young female mice fed a choline-deficient diet containing ethionine (CDE diet). The synergistic effect of choline deficiency and ethionine administration may be manipulated to achieve the desired mortality rates. Animals fed with choline-sufficient diets and ethionine 0.5% leads to a mortality rate approaching 10%. A choline-deficient diet without ethionine did not cause any mortality nor acute pancreatitis 99. By modifying the feeding protocol established by Lombardi et al. 98, Gilliland and Steer 100 were able to decrease the severity of diet-induced acute pancreatitis. The CDE diet was reduced in terms of amount (3 g per mouse) and duration (24 h). The exposure to CDE diet feeding was performed before and after 24 h of fasting. From this modification, a mortality rate between 50% and 60% resulted. Glucagon has been shown to reduce the mortality rate and severity of acute pancreatitis if administered prior to a CDE diet. Pancreatic polypeptide also decreased mortality rate and severity of acute pancreatitis. This model therefore allows gradation of the severity of acute pancreatitis and mortality for therapeutic trials or cell biological studies.

The advantage of the diet-induced model is that it is perhaps the simplest system to establish for the investigation of acute haemorrhagic pancreatitis. It is also cheap, highly reproducible and no surgical procedure is involved. Furthermore, by restricting the period of feeding, the mortality rate can be controlled at any desired level between 0% and 100% 101. The model is suitable for studying the pathophysiological aspects of the disease and the potential benefit of experimental treatment by measuring survival, biochemistry, histology, alterations in haematocrit, pH and blood gases 102. In comparison to the mild and oedematous varieties of acute pancreatitis produced by the caerulein model, this diet-induced model produces a haemorrhagic and necrotizing appearance of the disease with a lethal course. The inflammatory lesions in these models are homogeneously distributed. The model is substantially defined and reliably produces severe necrosis that approximates human acute pancreatitis. It has been demonstrated that both the gross and histological appearance of the pancreatic and peripancreatic inflammation, in addition to the clinical and biochemical course of diet-induced acute pancreatitis, reflect the human disease. The presence of ascites, acidosis, hypoxia and hypovolaemia can be found in this diet-induced model as well as in human acute pancreatitis.

Although the morphological alterations have many similar features between mouse and man 103, the relevance to the aetiology of human acute pancreatitis is doubtful. The model produces 80–100% mortality after 2–8 days. The mortality, however, may be related to causes other than acute pancreatitis. Independent of acute pancreatitis, animals also have changes in the liver and central nervous system which contribute to multiple organ failure.

Furthermore, the diet-induced model is species-specific and may be used only in mice, whose small size causes considerable technical limitations. The model is also sex-specific. In contrast, male mice are resistant to the induction of acute haemorrhagic pancreatitis by a choline-deficient diet containing DL-ethionine 104. Male mice with a body weight over 20 g usually show a less severe acute pancreatitis with a much lower mortality rate 49. The administration of oestrogen increases the susceptibility of male mice to acute pancreatitis 105. The onset of the acute pancreatitis is variable and careful monitoring is required to ensure that the intake of the CDE diet is the same in different experimental groups 99,101.

L-Arginine model

Another non-invasive rat model of acute pancreatitis was developed by Mizunuma et al. 106. This model produces acute necrotizing pancreatitis by administration of a large dose of L-arginine (Arg). The mortality is 2.5% 107. The mechanism by which Arg causes acute pancreatitis is currently unknown. It has been proposed that oxygen free radicals 108,109,110,111,112, nitric oxide 113, and inflammatory mediators 111,114,115,116 may be involved in the development of this disease. Hegyi et al. 107 noted that the weight of the pancreas almost doubled within 24 h. Under electron microscopy, Kishino et al. 117 noticed that degeneration began with the disarrangement of the rough endoplasmic reticulum in pancreatic acinar cells. Initial distension of the endoplasmic reticulum was followed by disarranged rough endoplasmic reticulum and degraded zymogen granules. This was followed by necrosis of acinar cells with leukocyte and fibroblast infiltration.

The single Arg injection model has been modified with varying results. Higher doses of > 500 mg/100 g bm can induce death within a few hours 118. Repeated dosing can increase the proportion of acinar cell necrosis. A single dose of 500 mg/100 g bm causes necrosis in up to 70–80% of the pancreatic acinar cells within 3 days, which increases to 90% with three further doses over 10 days 118. Reduced doses over a longer time period can also be used to delay the time of onset of acute pancreatitis 119.

In 2004, Hegyi et al. (107) characterized the early and late phases of the Arg-induced model in the rat. The early phase of acute pancreatitis is characterized by acute pancreatic inflammation with intercellular oedema infiltration of leukocytes, capillary dilatation and microfocal parenchyma necrosis. The acinar cells surrounding the Langerhans inlets remained intact. Prominent adipose tissue deposition was seen at the end of the first week. This adipose tissue accruement is an indication of atrophy in affected areas and may represent hypertrophy and hyperplasia in unaffected areas. The deaths of the rats occurred between days 1 and 5 following acute pancreatitis induction, with no mortality in control groups.

The benefits of the Arg-induced model include its high reproducibility and its ability to achieve selective dose-dependent pancreatic acinar cell necrosis. Due to the dose and time dependency of the effects of Arg, this model is very good for investigating the early and late phases of acute pancreatitis. A smaller dose of Arg is useful for characterizing the regenerative processes of acute pancreatitis. Long-term administration of Arg, however, results in chronic pancreatitis 119,120. This model is also useful for investigating the insulo-acinar axis. In a clinical situation, the circulatory, pulmonary, renal and hepatic failure (multi-organ failure) significantly affects the morbidity and mortality of acute pancreatitis 121,122,123. Thus, this model may be suitable for researching extra-pancreatic organ damage and its mechanisms.

Invasive experimental models

The highly variable severity of acute pancreatitis associated with the non-invasive models as well as the ill-defined temporal relationship of onset has led to the development of invasive models to overcome these problems (Table II). In addition, the aetiology of the non-invasive models has minimal relevance to the clinical situation. Most invasive animal models of acute pancreatitis simulate mechanisms relevant to gallstone-induced acute pancreatitis observed in clinical situations.

Table II. Summary of the advantages, disadvantages and clinical relevance of invasive experimental models of acute pancreatitis.

Model Advantages Disadvantages Clinical relevance References
Closed duodenal loop (CDL)
  • Relatively simple

  • Reproducible

  • Useful for studying the role of duodenal reflux in the pathogenesis of acute pancreatitis in humans

  • Suitable for experiments on small animals (i.e. rats) and thus economical

  • Requires surgical intervention, the non-physiologic pressure levels created in the closed duodenal compartment and the pancreatic duct, and the controversial role of bacterial infection

  • Not widely used

  • Closely resembles the few patients who develop acute pancreatitis in association with afferent loop obstruction after Billroth II gastrectomy

108,109,110,112,113,114,115
Antegrade pancreatic duct perfusion
  • Useful for studying early pathophysiology and subsequent progression of acute pancreatitis

  • Reliable

  • Reproducible

  • Pancreatitis severity may be varied within well-defined time intervals according to the volumes and perfusion pressures

  • Ideal for assessing potential therapeutic agents (i.e. cholecystokinin antagonists, somatostatin, fibrinolytic agents and cytokine antagonists)

  • Perfusion of an isolated segment of the rat pancreatic duct with bile salt increases its permeability; therefore smaller and cheaper animals can be used (i.e. rats)

  • Complex (ductal cannulation and perfusion)

  • Often requires large animals (i.e. cats) which are expensive and difficult to maintain

  • Aetiology and morphological changes closely resemble the human situation

126,127,128,129
Biliopancreatic duct injection
  • Suitable for studying systemic issues of acute pancreatitis

  • Useful for studying pseudocyst formation, pancreatic abscess and fatty tissue necrosis

  • Reproducible model for creating a severe, rapidly evolving, and lethal variety of acute haemorrhagic pancreatitis

  • Technically challenging to control constant pressure recordings and hence produce a standard degree of injury

  • Difficult to establish the degree of variation regarding tissue necrosis and survival in animal groups

  • Surgery is restricted to simulate the type of obstruction that would take place during the passage of gallstones via the papilla of Vater

  • Clinical and pathogenetic relevance unclear

  • Limited evidence to support the role of bile reflux in the human condition where the bile concentration in the general tissue is higher than the pancreatic tissue concentration

131,136,137,138
Combination of secretory hyperstimulation with minimal intraductal bile acid exposure
  • Combined action of low-dose intraductal GDOC with intravenous caerulein causes acute pancreatitis more reliably than induction by either component alone

  • Accelerated detergent effect is not elicited when using very low dose of GDOC (5 or 10 mmol/l); the bile salt is dispersed throughout the periphery of the pancreas

  • Relatively easy to perform

  • Reproducible

  • Relatively inexpensive

  • Mortality rates vary between 6% and 42% at 24 h

  • Pancreatic cell injury is progressive over at least 24 h

  • Produces homogeneous injury of intermediate rate of onset suitable for scoring and testing treatments

  • Pancreatic injury can be manipulated by controlling the amount and time of infusion of intraductal low-dose GDOC

  • High concentrations of bile acids produce extensive acinar necrosis too rapidly and the resulting lesions show substantial heterogeneity

  • Applying very low concentrations of GDOC (5 or 10 mmol/l) produces non-remarkable acute pancreatitis, with no death

Homogeneous injury has a moderately severe acute pancreatitis that impairs all regions of the gland, resembling human acute pancreatitis 139
Vascular-induced Microcirculatory disturbance
  • Acute haemorrhagic necrotizing pancreatitis can be reproduced by using microspheres of diameters < 20 µm

  • Induction of hypovolaemic shock significantly lowers pancreatic blood flow, thus may potentially be used to study pancreatic damage in cardiac surgery

  • Useful for studying coagulopathy and thrombosis of microvessels caused by acute pancreatitis

  • Allows the study of endothelin receptor antagonists (i.e. ET-RA, PAF-RA, ICAM-1-AB); ET-RA is most effective

Pancreatic artery occlusion
  • May potentially be used to study pancreatic damage in cardiac surgery

  • Allows relative preservation of islet cell function

Pancreatic venous occlusion
  • May be used to study acute splenic vein or portal vein thrombosis in acute pancreatitis

Overall
  • Vascular-induced models are relatively inexpensive

Microcirculatory disturbance
  • Maintaining the normality of other organs during the cannulation of pancreatic vessels is difficult

Pancreatic artery occlusion
  • Limited reproducibility

  • Pancreatic venous occlusion

  • Not suitable for investigating local changes in the pancreas

  • Not easily reproducible

Overall
  • Vascular-induced models do not reliably induce equivalent severity of acute pancreatitis

  • Reproducibility sometimes limited due to extensive collateral network of pancreatic circulation

  • Require large experimental animals

  • Surgical procedures are time-consuming

  • Minimal histological changes of acute pancreatitis

  • May eventually progress to chronic pancreatitis

  • In a clinical setting, acute pancreatitis caused by occlusion of a main artery is not a common event; it is sometimes observed in patients with arteritis

  • Microcirculatory disturbance models increase capillary permeability, similar to clinical situation

149,150,152,153,154,155,156
Ischaemia/reperfusion
  • Hoffman's model allows complete and reversible interruption of arterial blood supply to the pancreas

  • Intravital fluorescence microscopy enables the parameters of microcirculation during the entire reperfusion period to be assessed repetitively and quantitatively

  • Current models – incomplete ischaemia and inability to quantitate the remaining blood supply to the pancreas; irreversible ischaemia, making it unsuitable for reperfusion studies; and complete and reversible ischemia, limited to ex vivo models

  • Quantitative analysis of post-ischaemic reperfusion failure at the microcirculation level is difficult to achieve

  • Various methods, i.e. methylene blue or India ink injection, radioactive microspheres injection, light and electron microscopic analysis of microangiographic architecture or laser Doppler flowmetry cannot be used

  • Ultrastructural changes after 2 h of ischaemia simulate acinar structural changes in pancreas grafts following transplantation in human

154,163
Duct ligation
  • Avoids artificial drug usage that may produce unwanted systemic effects and the theory relating to clinical acute biliary acute pancreatitis with biliary pancreatic reflux

  • Cannot induce acute pancreatitis by surgical ligation of pancreatic duct alone

  • Most laboratory animals develop chronic lesions in the pancreas characterized by atrophy and apoptosis of acinar and ductal tissue, but not significant necrosis or inflammation

  • Technically difficult to perform

  • Expensive

  • Limited reproducibility

  • Analogous to chronic pancreatitis

  • Ligation of the common biliopancreatic duct in the rat causes a clinical syndrome resembling the multiple organ failure seen in humans

  • Main clinical correlation of duct ligation-induced pancreatitis is the acute pancreatitis seen after Polya gastrectomy

108,113,171,177,178,184
Duct-ligated Opossum/possum Opossum
  • Ligation of the pancreatic duct alone, bile and pancreatic duct separately, or the common biliopancreatic duct leads to severe acute pancreatitis

  • Mortality rates approach 100% within 2 weeks of induction

  • Useful for investigating pathophysiology of biliary acute pancreatitis

  • Necrosis is the primary mechanism; apoptosis is only present in the early stages of acute pancreatitis

Opossum Opossum
  • Closely simulates the mechanical events that occur during or after gallstone passage

179,180,181,182,184,186
Possum
  • Well characterized

  • Useful for studying the motility of the sphincter of Oddi (SO); it functions as a variable resistor in modulating bile and pancreatic secretion

  • Suitable for investigating the role of SO motility in other forms of acute pancreatitis, i.e. gallstone pancreatitis, and pancreatitis secondary to alcohol, scorpion envenomation, organophosphate poisoning, and octreotide treatment

  • Does not require gastroduodenostomy

  • Readily available

Possum
  • Co-existing duodenal wall necrosis, and pancreatic peritoneal sepsis often add complexity to the model; this complicates interpretation of results

Possum
  • The arrangement of the pancreatic and bile ducts come together and are controlled by an SO complex, resembling those of humans

  • Responses to hormonal and drug stimuli are similar to humans

Closed duodenal loop model

Experimental acute pancreatitis in animals may be produced by creating a closed duodenal loop (CDL). This technique involves surgically closing above and below the duodenal papilla while bile is diverted into the jejunum via an implanted cannula. The model was first developed by Pfeffer et al. 124 in an attempt to improve the extensive variability experienced when using the retrograde duct-injection models. Evidence of oedema, haemorrhage and necrosis of the pancreas developed within 9–11 h. No inflammation or fat necrosis was evident. Pfeffer et al. 124 concluded that the vascular factors influenced the formation of tissue necrosis. The CDL model is more representative as a model of pancreatic necrosis than as a model of pancreatic inflammatory disease.

This model has since undergone a number of modifications and has been employed in various animal species. In a study by Byrne and Joison 125, it was shown that acute haemorrhagic pancreatitis may be prevented by inserting antibiotics in the duodenum after a CDL had been performed. This suggests that the bacteria may contribute to the pathogenesis of acute haemorrhagic pancreatitis 125. The study by Nance et al. 126 however, demonstrated that the surgical creation of a CDL in germ-free dogs still induced acute pancreatitis. Furthermore, primates develop acute pancreatitis only if the CDL is combined with stimulation of the pancreas 127. Hence, differences between different animal species must be taken into account when considering this model. It is now clear that the mechanism of acute pancreatis is triggered by the reflux of duodenal contents into the pancreatic duct, and the pathogenesis in the CDL animal model is based on this principle.

Nevalainen and Seppa 128 also conducted a modification of CDL in rats. An intraduodenal tube was placed prior to ligating the duodenal loop in order to restore the continuity of the gastrointestinal tract. Within 24 h, acute haemorrhagic pancreatitis was visible in the animals. The findings support the view that reflux of the duodenal contents into the pancreatic duct is an important early pathogenetic mechanism in the development of acute pancreatitis. Chetty et al. 129 performed another modification of the technique by instilling infected bile into the closed loop under pressure, at a known time, in the rat. This resulted in the production of a lethal haemorrhage, periductal abscess formation and fat necrosis. The model of Chetty et al. 129 produces a consistently severe acute pancreatitis in comparison with the model produced by Nevalainen and Seppa 128.

Since the permanent ligation of the duodenum often caused death of the animal within a short period, some investigators have attempted temporary ligation of the duodenum in rats 130,131. This allowed them to examine the progression of acute pancreatitis at an extended time and to investigate potential therapies. In a study by Orda et al. 131, the authors injected a mixture of sodium taurocholate and trypsin into a temporary CDL to induce acute pancreatitis in rats. They found that the acute pancreatitis induced was mild, associated with a mortality rate of 45%. Recent studies have demonstrated a number of treatments that have an effect on both the course and severity of acute pancreatitis. These include protease inhibitors 131,132, trypsin inhibitors 134,135,136, somatostatin 137, prostaglandin E1138, vasopressin 139 and dextran 40 140.

The CDL model has helped address some of the issues regarding the aetiology of acute pancreatitis, specifically the role of duodenal reflux in the pathogenesis of the disease in humans. The model is advantageous because of its simplicity and reproducibility. It is suitable for experiments on small animals such as rats and thus is relatively economical. Disadvantages of this model include the need for surgical intervention, the non-physiologic pressure levels created in the closed duodenal compartment and the pancreatic duct, and the controversial role of bacterial infection. The CDL model is thought to closely resemble the few patients who develop acute pancreatitis in association with afferent loop obstruction after Billroth II gastrectomy. On the whole, the CDL technique has not been widely used due to the associated limitations and the availability of other models 141.

Antegrade pancreatic duct perfusion model

The antegrade duct perfusion model has played a significant role in the understanding of the underlying mechanisms in the initial induction of acute pancreatitis. The main pancreatic duct can be made permeable by the perfusion of glycodeoxycholic acid (GDOC) along the main pancreatic duct. Other methods include the administration of intragastric ethanol, the stimulation of pancreatic secretion into an obstructed duct, or causing acute hypercalcaemia. Thereafter, activated pancreatic enzymes are perfused via the main pancreatic duct using a cannula implanted into the duct in the tail of the pancreas. The perfusion pressure is maintained at 20 cm H2O, which is less than the maximal secretory pressure in the pancreas of the cat 142,143,144. Acute oedematous pancreatitis develops if activated pancreatic enzymes are perfused following early induced changes in ductal permeability 142. The initial mild acute oedematous pancreatitis may be converted into an acute necrotizing pancreatitis by simultaneous infusion of the stable prostaglandin analogue 16-16-dimethyl-prostanglandin E2143. This low-pressure duct perfusion model causes acute pancreatitis in cats resembling human changes and may be ideal for the study of severe necrotizing disease 142,143,144. Olazabal et al. 145 reported that perfusion of an isolated segment of the rat pancreatic duct with bile salt increased its permeability. Thus, this technique can be used on smaller animals, making it more economical.

The advantages of the pancreatic duct perfusion model are its reliability and reproducibility. The severity of the acute pancreatitis may be varied within well defined time intervals according to the volumes and perfusion pressures. The aetiology and the morphological changes closely resemble the human situation. This model is suitable for studying the early pathophysiology and subsequent progression of the disease. It is the ideal model to assess potential therapeutic agents, including CCK antagonists, somatostatin, fibrinolytic agents and cytokine antagonists (see references/review in Bilchik et al. 146). Furthermore, this model allows the ability to modify duct obstruction to study chronic pancreatitis.

The major disadvantage of this model is its complexity (ductal cannulation and perfusion). Other disadvantages include the need to use large animals such as cats which are expensive and difficult to maintain. However, once standardization is achieved, it remains one of the most suitable models to assess the underlying pathophysiology of severe acute pancreatitis and the effects of any therapeutic intervention.

Biliopancreatic duct injection model

Various compounds have been infused into the pancreatic duct to induce acute pancreatitis 147,148,149,150,151. Following a duodenotomy, a retrograde injection of bile salts (with or without activated pancreatic enzymes) into the pancreatic duct at the ampulla leads to severe acute pancreatitis. The severity of the disease can be manipulated by changing either the pressure or the concentration of bile salt used. Acute severe pancreatitis develops within 2–24 h and is characterized by oedema, necrosis and haemorrhage. Almost any form of detergent injected into the pancreatic duct under pressure will cause acute pancreatitis in laboratory animals such as dogs 152 and rats 147,153,154. One of the best standardized compounds to use to develop acute pancreatitis is sodium taurocholate. Infusion of 0.2 ml/kg of 3%, 4.5% or 5% solution induced acute haemorrhagic pancreatitis with 72-h mortality rates of 24%, 71% and 100%, respectively 147,153,154. This model is appropriate for studies of systemic issues.

The retrograde injection of bile salts into the pancreatic duct of animals is an easy, effective and reproducible model for creating a severe, rapidly evolving and lethal variety of acute haemorrhagic pancreatitis. This model may also be used to study pseudocyst formation, pancreatic abscess and fatty tissue necrosis. Haemorrhagic and necrotizing forms of acute pancreatitis have been reproducible for therapeutic studies when specific, low concentrations of bile salts 155,156 were used.

An important limitation of the biliopancreatic duct injection model is its clinical and pathogenetic relevance. There is limited evidence to support the role of bile reflux in the human condition where the bile concentration in the general tissue is higher than the pancreatic tissue concentration 157. It is also technically challenging to control constant pressure recordings and hence produce a standard degree of injury. Another disadvantage of this technique is the injection pressure with which the solution is applied to cause severe acute pancreatitis 158. Solutions such as normal saline can produce acute pancreatitis when injected to high pressures 159. Current studies have tried to overcome this artefact 160 by applying very low perfusion pressures and defined injection intervals to yield reproducible results 155. In addition, it is critical to establish the degree of variation regarding tissue necrosis and survival in the animal groups. Another limitation is that surgery is restricted to simulate the type of obstruction that would take place during the passage of gallstones via the papilla of Vater.

Combination of secretory hyperstimulation with minimal intraductal bile acid exposure model

A new model has been characterized by Schmidt et al. 155 to improve the limitations of acute pancreatitis models described above. This model involves a combined action of low-dose intraductal glycodeoxycholic acid (GDOC) with intravenous caerulein. The combination of both agents causes acute pancreatitis more reliably than induction by either component alone. This model produces a homogeneous injury with a moderately severe acute pancreatitis that impairs all regions of the gland, similar to human acute pancreatitis.

The disadvantage of this model is that a high concentration of GDOC (34 mmol/l) does not produce desirable results. It causes substantial acinar necrosis to form too quickly and the resulting lesions show considerable heterogeneity. On the other hand, using a very low dose of GDOC (5 or 10 mmol/l) is more advantageous because the accelerated detergent effect is not elicited. Furthermore, the bile salt is dispersed throughout the periphery of the pancreas. However, the limitation of applying very low concentrations of GDOC is that the acute pancreatitis produced is not remarkable, with no death.

This new model is advantageous because it is easy to perform, reproducible and inexpensive. The mortality rates vary between 6% and 42% at 24 h. In addition, the pancreatic cell injury produced is progressive over at least 24 h. The model produces homogeneous injury of intermediate rate of onset, which can be reliably scored for comparisons and enable treatment to be easily modulated. Pancreatic injury may be manipulated to become more severe and death is advanced by further increasing the amount and time of infusion of intraductal low-dose GDOC.

Vascular-induced model

Clinical syndromes associated with microvessel abnormalities are a rare cause of acute pancreatitis in humans. Acute pancreatitis may occur infrequently in polyarteritis nodosa, and in various coagulopathic states associated with microvascular thrombosis 161. Ischaemia from occlusion of the major arterial or venous supply of the pancreas may also be a rare cause of acute pancreatitis in humans. Various models have been developed to examine the vascular mechanism that produces acute pancreatitis.

Microcirculatory disorder is the major cause of death in the course of severe acute pancreatitis 162. Experimental evidence has shown that microcirculatory disturbances in this disease not only initiate tissue damage locally, but also in distant organs including the colon, liver, lungs and kidney 163. Hence, microcirculatory disorders are thought to be crucial in the development of acute pancreatitis-associated multiple organ dysfunction syndrome 164.

In 1962, Pfeffer et al. 165 found that intravascular injection with 10–20 µm microsphere diameter caused minimal oedema; 20–40 µm induced moderate oedema, parenchymal necrosis and inflammation; and 10–20 µm induced acute haemorrhagic necrotizing pancreatitis. There was also a significant increase in serum amylase levels. The results of this study were reproducible. A disadvantage of inducing acute pancreatitis by disturbing the pancreatic microcirculation is the difficulty in maintaining the normality of other organs during the cannulation of pancreatic vessels. The advantage of this method is that acute haemorrhagic necrotizing pancreatitis can be reproduced by using microspheres of diameters below 20 µm. This is particularly useful in the study of coagulopathy and thrombosis of microvessels caused by acute pancreatitis.

Other models have been developed to simulate the impairment of pancreatic inflow and outflow or the disturbances of the pancreatic microcirculation. In 1974, Lefer and Spath 166 induced hypovolaemic shock in dogs by bleeding them to a mean arterial pressure of 45 mmHg for 3 h. Electron microscopy showed that the lysosomes and zymogen granules became enlarged, and cathepsin D increased by 27-fold. Barzilai et al. 167 also used dogs to induce hypovolaemic shock. The dogs were bled for a period of 3 h to a higher mean arterial pressure of 60 mmHg. The authors found oedema and acinar cell necrosis in the pancreas. They also found that hypovolaemic shock significantly lowered pancreatic blood flow. The model may potentially be used to study pancreatic damage in cardiac surgery 168. This model is now specific and produces multiple systemic hypotensive changes.

There is experimental evidence that microcirculatory disturbances involve not only decreased capillary blood flow but also enhanced leukocyte–endothelial interaction and increased capillary permeability 169. High capillary permeability, in particular, represents a relevant clinical problem. Several studies have attempted blocking vasoactive mediators such as endothelin (ET-1), platelet-activating factor (PAF) and intercellular adhesion molecule-1 (ICAM-1), in the same model of severe acute pancreatitis to study their effects. Eibl et al. 169 noted that endothelin receptor antagonist (ET-RA), PAF receptor antagonist (PAF-RA) and intercellular adhesion molecule-1 antibody (ICAM-1-AB) improved microcirculation in acute pancreatitis, confirming previous studies. Moreover, the authors found that ET-RA is the most effective in reducing microcirculatory disorders, particularly in decreasing capillary leakage. Therefore, endothelial receptor blockade could be useful for a clinical trial to attenuate capillary leakage in individuals with acute pancreatitis.

In addition, various studies have been performed to occlude pancreatic arteries. In 1986, Spormann et al. 170 occluded the coeliac axis and the superior mesenteric artery for 20 min and found a three-fold increase in serum amylase after 4 h. They did not find any histological changes in the pancreas. In another study, Pfeffer et al. (165) performed a permanent ligation of the superior pancreaticoduodenal artery and observed a rise in pancreatic enzymes and parenchymal necrosis in the head region of the pancreas. The main disadvantage of this model is its limited reproducibility. Redha et al. 171 also reported an induction of acute haemorrhagic pancreatitis by partially occluding the arterial supply to the pancreas of the rat. This technique required a laparotomy and delivering the spleen into the wound. A microcannula was used to isolate a distal branch of the splenic artery. Polystyrene microspheres were introduced into the artery. The cannula was then removed and the vessel ligated. Alterations of the pancreas can be identified within 30 min of induction by immunohistochemical techniques 171. Within 24 h, there was extensive pancreatic oedema, inflammatory cell infiltrate, haemorrhage and fat necrosis 171. An advantage of the pancreatic artery occlusion model is relative preservation of islet cell function 97. On the whole, pancreatic artery occlusion models are not useful for investigating acute pancreatitis. In a clinical setting, acute pancreatitis caused by occlusion of a main artery is not a common event. It is sometimes observed in patients with arteritis.

A number of studies have also been performed to study the occlusion of pancreatic veins. Pfeffer et al. 165 investigated the permanent occlusion of the pancreatic outflow in dogs. They injected microspheres of 20–40 µm diameter via the superior pancreaticoduodenal vein into the pancreas. The pancreas and serum amylase remained normal. There was also no evidence of morphological changes in the pancreas. In contrast, Sjovall et al. 172 found a four-fold increase in amylase concentration in rats after ligating the splenic and superior pancreaticoduodenal vein. They also observed oedema and interstitial haemorrhage in the pancreas 25 h after ligation. Shibayama et al. 173 found mild oedema and haemorrhage in the pancreas within 24 h of partial or complete venous obstruction in rats. The major disadvantage of occluding pancreatic veins is its unsuitability for investigating local changes in the pancreas. Furthermore, partial vein occlusion is not easily reproducible. The pancreatic venous occlusion model may be used to study the pathophysiology of acute pancreatitis in acute splenic vein or portal vein thrombosis.

The advantage of the vascular model is that it is relatively inexpensive. The model does not reliably induce equivalent severity of acute pancreatitis. The reproducibility of this model is sometimes limited because of the extensive collateral network of the pancreatic circulation. It is however, important for studying microcirculatory disturbances that may take place in acute pancreatitis as a result of coagulopathy and microvascular thrombosis 161. The disadvantages of this model are the requirements of large experimental animals and time-consuming surgical procedures. Although temporary arterial occlusion shows a transient rise in circulating pancreatic enzymes, histological changes of acute pancreatitis are minimal. Overall, the vascular-induced model has not been particularly useful in investigating acute pancreatitis. There is evidence 174 that this model may ultimately advance to chronic pancreatitis and may be a useful tool to investigate the chronic form of this disease.

Ischaemia/reperfusion model

Both clinical and experimental studies have shown that ischaemic injury plays an important part in the pathogenesis of acute pancreatitis. Ischaemic injury to the pancreas is known to occur in various clinical settings including cardiopulmonary bypass 175, haemorrhagic shock 168 and transplantation of the gland 176. Studies have shown that there is correlation between the impairment of microcirculation in human pancreas with the degree of ischaemic injury 177, and microvasculature presents the primary target of reperfusion injury after ischaemia 178. In recent years, animal models have been developed to investigate the ischaemia/reperfusion of the pancreas.

In 1995, Hoffman et al. 179 developed a model to study the microcirculation of the pancreas in the rat after complete (interruption of arterial blood supply to the pancreas) and reversible ischaemia of the pancreas using intravital fluorescence microscopy. Blood supply for complete ischaemia of the pancreas was impaired by isolating arteries from surrounding tissue of gastroduodenal artery, left gastric artery, splenic artery and caudal pancreaticoduodenal artery. Complete but reversible ischaemia of the pancreas was induced by occluding the four vessels using microvascular clips. The clips were taken out 30 min, 1 h or 2 h after ischaemia to produce reperfusion.

The characteristics noted following ischaemia/reperfusion in the pancreas were similar to those observed in the sodium taurocholate-induced acute pancreatitis model 179. The duration of ischaemia and of reperfusion is responsible for the severity of post-ischaemic inflammatory reaction. In addition, there was a rise in the concentration of serum amylase after 1 and 2 h of ischaemia 179. Similar results were observed by another group after 2 h of ischaemia and 4 h of reperfusion 180. Redha et al. 171 reported even higher serum amylase concentrations after ischaemia-induced acute pancreatitis. This may occur because of the extended time (27 h) of reperfusion. Under light and electron microscopy, the histological changes resembled those seen in the caerulein-induced acute pancreatitis in the rat 181. Ultrastructural changes after 2 h of ischaemia simulate acinar structural changes in pancreas grafts following transplantation in human 182,183.

The current models used to induce ischaemia have a number of restrictions involving reproducibility. These limitations include incomplete ischaemia and inability to quantitate the remaining blood supply to the pancreas; irreversible ischaemia, making it not suitable for reperfusion studies; and complete and reversible ischaemia, limited to ex vivo models 179. Furthermore, quantitative analysis of the post-ischaemic reperfusion failure at the microcirculation level is also difficult to achieve. Various methods such as methylene blue or India ink injection, radioactive microspheres injection, light and electron microscopic analysis of microangiographic architecture or laser Doppler flowmetry cannot be used 184,185,186. The advantage of the model developed by Hoffman et al. 179 is that it enables complete and reversible interruption of arterial blood supply to the pancreas. By using the intravital fluorescence microscopy, the parameters of microcirculation during the entire reperfusion period can be assessed repetitively and quantitatively 179.

Duct ligation model

Acute pancreatitis may be induced by ligating the distal bile duct at the level of the duodenum 187. This creates an early development of acute pancreatitis, obstructive jaundice and cholangitis in the rat. The duct ligation model was developed in an attempt to resemble the clinical situation of gallstones, motility disorders of the sphincter, oedema and strictures at the papilla, tumours of the papilla, and parasites impacting the terminal biliopancreatic duct.

Surgical ligation of the pancreatic duct alone has not been successful in inducing acute pancreatitis. Most laboratory animals developed chronic lesions in the pancreas characterized by atrophy and apoptosis of acinar and ductal tissue, but not significant necrosis or inflammation 188. The ligation of the pancreatic duct in rodents has become an established model for chronic pancreatic atrophy and is often used for studying pancreatic regeneration 189,190. Ligation of this common biliopancreatic duct in the rat, however, causes a clinical syndrome resembling the multiple organ failure observed in man. These characteristics included pancreatic necrosis and haemorrhage, white cell infiltration and multiple microthrombi in the lung, stomach and kidney 191.

When Popper and Necheles 192 combined pancreatic duct ligation with the secretory stimulation, secretin in dogs, mild acute oedematous pancreatitis with fat necrosis was observed. Another study combining duct ligation with both secretory stimulation and minimal arterial blood produced a greater degree of severity of acute pancreatitis 193. Due to its anatomical characteristics, the opossum has been used to produce severe acute haemorrhagic necrotizing pancreatitis. This laboratory animal has a pancreatic main duct which drains into a long common bile duct and both enter the duodenum at the papilla 194,195. Ligation of the pancreatic duct alone, bile and pancreatic duct separately, or the common biliopancreatic duct leads to severe acute pancreatitis with mortality rates approaching 100% within 2 weeks of induction 196,197. The American opossum model was frequently used to investigate the pathophysiology of biliary acute pancreatitis.

This model of duct obstruction in the opossum is useful because it closely simulates the mechanical events that occur during or after gallstone passage 198. Using this model, acinar cell necrosis could be identified as being the early point of injury in acute necrotizing pancreatitis 194. Studies have shown that in duct-ligated rats, the predominant mechanism of cell death is apoptosis 199. In duct-ligated opossums, necrosis is the primary mechanism; apoptosis is only present in the early phase of acute pancreatitis 199. Gukovskaya et al. 199 showed that the extent of pancreatitic necrosis from duct-ligated opossums corresponds with the elevated levels of neutrophil infiltration. Neutrophils are thought to produce mediators such as hydrogen peroxide and oxygen that may be responsible for triggering necrosis 199. Pancreatic outflow obstruction seems to be the critical pathophysiological event for the induction of acute pancreatitis 195. It appears that bile reflux is not required for the pathogenesis of acute pancreatitis in this model.

It has been suggested that induced sphincter of Oddi (SO) dysfunction may be the cause of pancreatic duct obstructions 200. A recent study using Australian brush tailed possums (Trichosurus vulpecula), has shown for the first time, that induced SO dysfunction when combined with stimulated pancreatic secretion produces acute pancreatitis. Chen et al. 201 demonstrated that transient obstruction of the SO produced by carbachol administration led to hyperamylasaemia and the histological changes correlated with acute pancreatitis. These results were similar to those induced in possums coupled with pancreatic duct ligation and CCK-8/secretin administration 201, a method well established in inducing hyperamylasaemia and acute pancreatitis in other species. Both these models required the simultaneous increase in pancreatic duct pressure with a combination of stimulated pancreatic exocrine to produce hyperamylasaemia and acute pancreatitis 201.

This newly described possum model has been well characterized. The model is useful for studying the motility of the SO because it functions as a variable resistor in modulating bile and pancreatic secretion 202. The arrangement of the pancreatic and bile ducts come together and are controlled by an SO complex, resembling those of humans. In addition, the responses to hormonal and drug stimuli are comparable to humans 203. This model is also suitable for investigating the role of SO motility in other forms of acute pancreatitis such as gallstone pancreatitis, and pancreatitis secondary to alcohol, scorpion envenomation, organophosphate poisoning and octreotide treatment 200.

The duct ligation-induced model mainly correlates with the clinical acute pancreatitis seen after Polya gastrectomy. The advantage of the duct ligation model is that it avoids artificial drug usage which may produce unwanted systemic effects, as well as the theory relating to clinical acute biliary acute pancreatitis with biliary pancreatic reflux 197. However, the complexity, technical difficulty, high cost, limited reproducibility and the analogy to chronic pancreatitis, have made the duct ligation model infrequently used for investigating acute pancreatitis. Chetty et al. 129 modified this model in the rat so that gastroduodenostomy was not required. This model involves a plastic tube to traverse the CDL to restore gastrointestinal continuity. In comparison to the conventional model developed by Pfeffer et al. 124, the modified model is cheaper and more readily available. However, the co-existing duodenal wall necrosis and pancreatic peritoneal sepsis often add complexity to the model. This complicates interpretation of the results 129.

Conclusion

In view of the methodological restrictions of the established acute pancreatitis models for therapy investigation, many attempts have been made to develop, modify or combine available models to more closely resemble human acute pancreatitis. However, none of the existing experimental models are completely satisfactory at the present time. Therefore, comparison between the existing models is complex and interpretations of results from various studies are consequently difficult. The challenge is exposing the animals to the same degree of severity that triggers acute pancreatitis in man, such as alcohol, bile duct obstruction, pancreatic ischaemia, traumatic damage and various toxic substances. Although the current experimental models are not closely comparable to all the spectrum of human acute pancreatitis, previously reported studies should not be dismissed. Much of our current knowledge has stemmed from existing experimental models; they have contributed to our knowledge of mechanisms involved in early cellular events, pathogenesis and pathophysiology of acute pancreatitis. It has been shown that certain models are better suited for answering specific questions than others. Further understanding and standardization of these models may enable us to choose the most appropriate model for studying a given aspect of acute pancreatitis or for evaluating new treatment protocols. Thus, continued research refining the present experimental design is required in this area because the discovery of effective treatments for acute pancreatitis will be extremely beneficial.

Acknowledgements

Austin Hospital Medical Research Foundation Project Grant 2004.

References

  • 1.Steinberg SM, Gower WR, Jr, Martin D, Carey LC, Cloutier CT. Experimental pancreatitis does not produce pulmonary hypertension. Surg Gynecol Obstet. 1983;157:530–3. [PubMed] [Google Scholar]
  • 2.Toouli J, Brooke-Smith M, Bassi C, Carr-Locke D, Telford J, Freeny P, et al. Guidelines for the management of acute pancreatitis. J Gastroenterol Hepatol. 2002;17(Suppl):S15–S39. doi: 10.1046/j.1440-1746.17.s1.2.x. [DOI] [PubMed] [Google Scholar]
  • 3.Bradley EL., 3rd A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga, September 11 through 13, 1992. Arch Surg. 1993;128:586–90. doi: 10.1001/archsurg.1993.01420170122019. [DOI] [PubMed] [Google Scholar]
  • 4.Banks PA. Practice guidelines in acute pancreatitis. Am J Gastroenterol. 1997;92:377–86. [PubMed] [Google Scholar]
  • 5.Beger HG, Bittner R, Block S, Buchler M. Bacterial contamination of pancreatic necrosis. A prospective clinical study. Gastroenterology. 1986;91:433–8. doi: 10.1016/0016-5085(86)90579-2. [DOI] [PubMed] [Google Scholar]
  • 6.Steer ML, Meldolesi J. Pathogenesis of acute pancreatitis. Annu Rev Med. 1988;39:95–105. doi: 10.1146/annurev.me.39.020188.000523. [DOI] [PubMed] [Google Scholar]
  • 7.Steer ML. Workshop on experimental pancreatitis. Dig Dis Sci. 1985;30:575–81. doi: 10.1007/BF01320266. [DOI] [PubMed] [Google Scholar]
  • 8.Frossard JL, Hadengue A. [Acute pancreatitis: new physiopathological concepts] Gastroenterol Clin Biol 2001;25:164–76(in French). [PubMed] [Google Scholar]
  • 9.Frossard JL, Hadengue A, Pastor CM. New serum markers for the detection of severe acute pancreatitis in humans. Am J Respir Crit Care Med. 2001;164:162–70. doi: 10.1164/ajrccm.164.1.2008026. [DOI] [PubMed] [Google Scholar]
  • 10.Pastor CM, Frossard JL. Are genetically modified mice useful for the understanding of acute pancreatitis? FASEB J. 2001;15:893–7. doi: 10.1096/fj.00-0672rev. [DOI] [PubMed] [Google Scholar]
  • 11.Saluja AK, Steer MLP. Pathophysiology of pancreatitis. Role of cytokines and other mediators of inflammation. Digestion. 1999;60(Suppl 1):27–33. doi: 10.1159/000051450. [DOI] [PubMed] [Google Scholar]
  • 12.Frossard JL. Trypsin activation peptide (TAP) in acute pancreatitis: from pathophysiology to clinical usefulness. JOP. 2001;2:69–77. [PubMed] [Google Scholar]
  • 13.Frossard JL. Trypsinogen activation peptide in acute pancreatitis. Lancet. 2000;356:766–7. doi: 10.1016/S0140-6736(05)73665-5. [DOI] [PubMed] [Google Scholar]
  • 14.Frossard JL, Robert J, Soravia C, Mensi N, Magnin A, Hadengue A, et al. Early prediction in acute pancreatitis: the contribution of amylase and lipase levels in peritoneal fluid. JOP. 2000;1:36–45. [PubMed] [Google Scholar]
  • 15.Robert JH, Frossard JL, Mermillod B, Soravia C, Mensi N, Roth M, et al. Early prediction of acute pancreatitis: prospective study comparing computed tomography scans, Ranson, Glasgow, Acute Physiology and Chronic Health Evaluation II scores, and various serum markers. World J Surg. 2002;26:612–19. doi: 10.1007/s00268-001-0278-y. [DOI] [PubMed] [Google Scholar]
  • 16.Frossard JL. Pathophysiology of acute pancreatitis: a multistep disease. Acta Gastroenterol Belg. 2003;66:166–73. [PubMed] [Google Scholar]
  • 17.Norman J. The role of cytokines in the pathogenesis of acute pancreatitis. Am J Surg. 1998;175:76–83. doi: 10.1016/s0002-9610(97)00240-7. [DOI] [PubMed] [Google Scholar]
  • 18.Rinderknecht H. Fatal pancreatitis, a consequence of excessive leukocyte stimulation? Int J Pancreatol. 1988;3:105–12. doi: 10.1007/BF02798921. [DOI] [PubMed] [Google Scholar]
  • 19.Demols A, Le Moine O, Desalle F, Quertinmont E, Van Laethem JL, Deviere J. CD4(+)T cells play an important role in acute experimental pancreatitis in mice. Gastroenterology. 2000;118:582–90. doi: 10.1016/s0016-5085(00)70265-4. [DOI] [PubMed] [Google Scholar]
  • 20.Frossard JL, Saluja AK, Mach N, Lee HS, Bhagat L, Hadenque A, et al. In vivo evidence for the role of GM-CSF as a mediator in acute pancreatitis-associated lung injury. Am J Physiol Lung Cell Mol Physiol. 2002;283:L541–8. doi: 10.1152/ajplung.00413.2001. [DOI] [PubMed] [Google Scholar]
  • 21.Saluja A, Hofbauer B, Yamaguchi Y, Yamanaka K, Steer M. Induction of apoptosis reduces the severity of caerulein-induced pancreatitis in mice. Biochem Biophys Res Commun. 1996;220:875–8. doi: 10.1006/bbrc.1996.0498. [DOI] [PubMed] [Google Scholar]
  • 22.Bhatia M, Wallig MA, Hofbauer B, Lee HS, Frossard JL, Steer ML, et al. Induction of apoptosis in pancreatic acinar cells reduces the severity of acute pancreatitis. Biochem Biophys Res Commun. 1998;246:476–83. doi: 10.1006/bbrc.1998.8519. [DOI] [PubMed] [Google Scholar]
  • 23.Sweiry JH, Mann GE. Role of oxidative stress in the pathogenesis of acute pancreatitis. Scand J Gastroenterol Suppl. 1996;219:10–15. doi: 10.3109/00365529609104992. [DOI] [PubMed] [Google Scholar]
  • 24.Schoenberg MH, Buchler M, Gaspar M, Stinner A, Younes M, Melzner I, et al. Oxygen free radicals in acute pancreatitis of the rat. Gut. 1990;31:1138–43. doi: 10.1136/gut.31.10.1138. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Nonaka A, Manabe T, Kyogoku T, Tamura K, Tobe T. Changes in lipid peroxide and oxygen radical scavengers in cerulein-induced acute pancreatitis. Imbalance between the offense and defense systems. Digestion. 1990;47:130–7. doi: 10.1159/000200487. [DOI] [PubMed] [Google Scholar]
  • 26.Neuschwander-Tetri BA, Ferrell LD, Sukhabote RJ, Grendell JH. Glutathione monoethyl ester ameliorates caerulein-induced pancreatitis in the mouse. J Clin Invest. 1992;89:109–16. doi: 10.1172/JCI115550. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Dabrowski A, Gabryelewicz A. Oxidative stress. An early phenomenon characteristic of acute experimental pancreatitis. Int J Pancreatol. 1992;12:193–9. [PubMed] [Google Scholar]
  • 28.Lander HM. An essential role for free radicals and derived species in signal transduction. FASEB J. 1997;11:118–24. [PubMed] [Google Scholar]
  • 29.Fallon MB, Gorelick FS, Anderson JM, Mennone A, Saluja A, Steer ML. Effect of cerulein hyperstimulation on the paracellular barrier of rat exocrine pancreas. Gastroenterology. 1995;108:1863–72. doi: 10.1016/0016-5085(95)90151-5. [DOI] [PubMed] [Google Scholar]
  • 30.Schulz HU, Niederau C, Klonowski-Stumpe H, Halangk W, Luthen R, Lippert H. Oxidative stress in acute pancreatitis. Hepatogastroenterology. 1999;46:2736–50. [PubMed] [Google Scholar]
  • 31.Lampel M, Kern HF. Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue. Virchows Arch A Pathol Anat Histol. 1977;373:97–117. doi: 10.1007/BF00432156. [DOI] [PubMed] [Google Scholar]
  • 32.Watanabe O, Baccino FM, Steer ML, Meldolesi J. Supramaximal caerulein stimulation and ultrastructure of rat pancreatic acinar cell: early morphological changes during development of experimental pancreatitis. Am J Physiol. 1984;246((4 Pt 1)):G457–67. doi: 10.1152/ajpgi.1984.246.4.G457. [DOI] [PubMed] [Google Scholar]
  • 33.Niederau C, Ferrell LD, Grendell JH. Caerulein-induced acute necrotizing pancreatitis in mice: protective effects of proglumide, benzotript, and secretin. Gastroenterology. 1985;88((5 Pt 1)):1192–204. doi: 10.1016/s0016-5085(85)80079-2. [DOI] [PubMed] [Google Scholar]
  • 34.Renner IG, Wisner JR. Exogenous secretin ameliorates ceruletide induced acute pancreatitis in the dog. Dig Dis Sci 1983;28:946.(abstract). [DOI] [PubMed] [Google Scholar]
  • 35.Adler G, Kern HF, Scheele GA. Go VWL, et al. Raven; New York: 1986. Experimental models and concepts in acute pancreatitis, The exocrine pancreas: biology, pathobiology, diseases. [Google Scholar]
  • 36.Konturek SJ, Dembinski A, Konturek PJ, Warzecha Z, Jaworek J, Gustaw P, et al. Role of platelet activating factor in pathogenesis of acute pancreatitis in rats. Gut. 1992;33:1268–74. doi: 10.1136/gut.33.9.1268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Lankisch PG, Koop H, Winckler K, Folsch UR, Creutzfeldt W. Somatostatin therapy of acute experimental pancreatitis. Gut. 1977;18:713–16. doi: 10.1136/gut.18.9.713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Adler G, Gerhards G, Schick J, Rohr G, Kern HF. Effects of in vivo cholinergic stimulation of rat exocrine pancreas. Am J Physiol. 1983;244:G623–9. doi: 10.1152/ajpgi.1983.244.6.G623. [DOI] [PubMed] [Google Scholar]
  • 39.Kern HF, Adler G, Scheele GA. Structural and biochemical characterization of maximal and supramaximal hormonal stimulation of rat exocrine pancreas. Scand J Gastroenterol Suppl. 1985;112:20–9. doi: 10.3109/00365528509092209. [DOI] [PubMed] [Google Scholar]
  • 40.Adler G, Hupp T, Kern HF. Course and spontaneous regression of acute pancreatitis in the rat. Virchows Arch A Pathol Anat Histol. 1979;382:31–47. doi: 10.1007/BF01102739. [DOI] [PubMed] [Google Scholar]
  • 41.Adler G, Rohr G, Kern HF. Alteration of membrane fusion as a cause of acute pancreatitis in the rat. Dig Dis Sci. 1982;27:993–1002. doi: 10.1007/BF01391745. [DOI] [PubMed] [Google Scholar]
  • 42.Guice KS, Oldham KT, Johnson KJ, Kunkel RG, Morganroth ML, Ward PA. Pancreatitis-induced acute lung injury. An ARDS model. Ann Surg. 1988;208:71–7. doi: 10.1097/00000658-198807000-00010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Willemer S, Feddersen CO, Karges W, Adler G. Functional and morphological pulmonary changes in cerulein-induced pancreatitis in the rat. Dig Dis Sci. 1987;32:1190. [Google Scholar]
  • 44.Kloppel G, Dreyer T, Willemer S, Kern HF, Adler G. Human acute pancreatitis: its pathogenesis in the light of immunocytochemical and ultrastructural findings in acinar cells. Virchows Arch A Pathol Anat Histopathol. 1986;409:791–803. doi: 10.1007/BF00710764. [DOI] [PubMed] [Google Scholar]
  • 45.Willemer S, Adler G. Histochemical and ultrastructural characteristics of tubular complexes in human acute pancreatitis. Dig Dis Sci. 1989;34:46–55. doi: 10.1007/BF01536153. [DOI] [PubMed] [Google Scholar]
  • 46.Willemer S, Kloppel G, Kern HF, Adler G. Immunocytochemical and morphometric analysis of acinar zymogen granules in human acute pancreatitis. Virchows Arch A Pathol Anat Histopathol. 1989;415:115–23. doi: 10.1007/BF00784348. [DOI] [PubMed] [Google Scholar]
  • 47.Bartholomew C. Acute scorpion pancreatitis in Trinidad. Br Med J. 1970;1:666–8. doi: 10.1136/bmj.1.5697.666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Dressel TD, Goodale RL, Jr, Arneson MA, Borner JW. Pancreatitis as a complication of anticholinesterase insecticide intoxication. Ann Surg. 1979;189:199–204. doi: 10.1097/00000658-197902000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Pantoja JL, Renner IG, Abramson SB, Edmondson HA. Production of acute hemorrhagic pancreatitis in the dog using venom of the scorpion, Buthus quinquestriatus. Dig Dis Sci. 1983;28:429–39. doi: 10.1007/BF02430532. [DOI] [PubMed] [Google Scholar]
  • 50.Dressel TD, Goodale RL, Jr, Zweber B, Borner JW. The effect of atropine and duct decompression on the evolution of Diazinon-induced acute canine pancreatitis. Ann Surg. 1982;195:424–34. doi: 10.1097/00000658-198204000-00008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Siech M, Heinrich P, Letko G. Development of acute pancreatitis in rats after single ethanol administration and induction of a pancreatic juice edema. Int J Pancreatol. 1991;8:169–75. doi: 10.1007/BF02924430. [DOI] [PubMed] [Google Scholar]
  • 52.Andrzejewska A, Dlugosz JW, Jurkowska G. The effect of antecedent acute ethanol ingestion on the pancreas ultrastructure in taurocholate pancreatitis in rats. Exp Mol Pathol. 1998;65:64–77. doi: 10.1006/exmp.1998.2226. [DOI] [PubMed] [Google Scholar]
  • 53.Foitzik T, Lewandrowski KB, Fernandez-del Castillo C, Rattner DW, Klar E, Warshaw AL. Exocrine hyperstimulation but not pancreatic duct obstruction increases the susceptibility to alcohol-related pancreatic injury. Arch Surg. 1994;129:1081–5. doi: 10.1001/archsurg.1994.01420340095018. [DOI] [PubMed] [Google Scholar]
  • 54.Letko G, Nosofsky T, Lessel W, Siech M. Transition of rat pancreatic juice edema into acute pancreatitis by single ethanol administration. Pathol Res Pract. 1991;187:247–50. doi: 10.1016/S0344-0338(11)80779-X. [DOI] [PubMed] [Google Scholar]
  • 55.Luthen RE, Niederau C, Grendell JH. Glutathione and ATP levels, subcellular distribution of enzymes, and permeability of duct system in rabbit pancreas following intravenous administration of alcohol and cerulein. Dig Dis Sci. 1994;39:871–9. doi: 10.1007/BF02087436. [DOI] [PubMed] [Google Scholar]
  • 56.Quon MG, Kugelmas M, Wisner JR, Jr, Chandrasoma P, Valenzuela JE. Chronic alcohol consumption intensifies caerulein-induced acute pancreatitis in the rat. Int J Pancreatol. 1992;12:31–9. doi: 10.1007/BF02927068. [DOI] [PubMed] [Google Scholar]
  • 57.Schneider A, Whitcomb DC, Singer MV. Animal models in alcoholic pancreatitis – what can we learn? Pancreatology. 2002;2:189–203. doi: 10.1159/000058033. [DOI] [PubMed] [Google Scholar]
  • 58.Katz M, Carangelo R, Miller LJ, Gorelick F. Effect of ethanol on cholecystokinin-stimulated zymogen conversion in pancreatic acinar cells. Am J Physiol. 1996;270((1 Pt 1)):G171–5. doi: 10.1152/ajpgi.1996.270.1.G171. [DOI] [PubMed] [Google Scholar]
  • 59.Saluja AK, Lu L, Yamaguchi Y, Hofbauer B, Runzi M, Dawra R, et al. A cholecystokinin-releasing factor mediates ethanol-induced stimulation of rat pancreatic secretion. J Clin Invest. 1997;99:506–12. doi: 10.1172/JCI119186. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Lerch MM, Albrecht E, Ruthenburger M, Mayerle J, Halangk W, Kruger B. Pathophysiology of alcohol-induced pancreatitis. Pancreas. 2003;27:291–6. doi: 10.1097/00006676-200311000-00003. [DOI] [PubMed] [Google Scholar]
  • 61.Pandol SJ, Periskic S, Gukovsky I, Zaninovic V, Jung Y, Zong Y, et al. Ethanol diet increases the sensitivity of rats to pancreatitis induced by cholecystokinin octapeptide. Gastroenterology. 1999;117:706–16. doi: 10.1016/s0016-5085(99)70465-8. [DOI] [PubMed] [Google Scholar]
  • 62.Ponnappa BC, Marciniak R, Schneider T, Hoek JB, Rubin E. Ethanol consumption and susceptibility of the pancreas to cerulein-induced pancreatitis. Pancreas. 1997;14:150–7. doi: 10.1097/00006676-199703000-00007. [DOI] [PubMed] [Google Scholar]
  • 63.Ramo OJ. Antecedent long term ethanol consumption in combination with different diets alters the severity of experimental acute pancreatitis in rats. Gut. 1987;28:64–9. doi: 10.1136/gut.28.1.64. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Siech M, Weber H, Letko G, Dummler W, Schoenberg MH, Beger HG. Similar morphological and intracellular biochemical changes in alcoholic acute pancreatitis and ischemic acute pancreatitis in rats. Pancreas. 1997;14:32–8. doi: 10.1097/00006676-199701000-00006. [DOI] [PubMed] [Google Scholar]
  • 65.Wedgwood KR, Adler G, Kern H, Reber HA. Effects of oral agents on pancreatic duct permeability. A model of acute alcoholic pancreatitis. Dig Dis Sci. 1986;31:1081–8. doi: 10.1007/BF01300261. [DOI] [PubMed] [Google Scholar]
  • 66.Friedman HS, Lowery R, Shaughnessy E, Scorza J. The effects of ethanol on pancreatic blood flow in awake and anesthetized dogs. Proc Soc Exp Biol Med. 1983;174:377–82. doi: 10.3181/00379727-174-41751. [DOI] [PubMed] [Google Scholar]
  • 67.Lu Z, Karne S, Kolodecik T, Gorelick FS. Alcohols enhance caerulein-induced zymogen activation in pancreatic acinar cells. Am J Physiol Gastrointest Liver Physiol. 2002;282:G501–7. doi: 10.1152/ajpgi.00388.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Weber H, Merkord J, Jonas L, Wagner A, Schroder H, Kading U, et al. Oxygen radical generation and acute pancreatitis: effects of dibutyltin dichloride/ethanol and ethanol on rat pancreas. Pancreas. 1995;11:382–8. doi: 10.1097/00006676-199511000-00010. [DOI] [PubMed] [Google Scholar]
  • 69.Werner J, Laposata M, Fernandez-del Castillo C, Saghir M, Iozzo RV, Lewandrowski KB, et al. Pancreatic injury in rats induced by fatty acid ethyl ester, a nonoxidative metabolite of alcohol. Gastroenterology. 1997;113:286–94. doi: 10.1016/s0016-5085(97)70106-9. [DOI] [PubMed] [Google Scholar]
  • 70.Abcouwer SF, Norman J, Fink G, Carter G, Lustig RJ, Souba WW. Tissue-specific regulation of glutamine synthetase gene expression in acute pancreatitis is confirmed by using interleukin-1 receptor knockout mice. Surgery 1996;120:255–63; discussion 263–4. [DOI] [PubMed] [Google Scholar]
  • 71.Norman JG, Fink GW, Sexton C, Carter G. Transgenic animals demonstrate a role for the IL-1 receptor in regulating IL-1beta gene expression at steady-state and during the systemic stress induced by acute pancreatitis. J Surg Res. 1996;63:231–6. doi: 10.1006/jsre.1996.0253. [DOI] [PubMed] [Google Scholar]
  • 72.Denham W, Yang J, Norman J. Evidence for an unknown component of pancreatic ascites that induces adult respiratory distress syndrome through an interleukin-1 and tumor necrosis factor-dependent mechanism. Surgery 1997;122:295–301; discussion 301–2. [DOI] [PubMed] [Google Scholar]
  • 73.Denham W, Yang J, Fink G, Denham D, Carter G, Ward K, et al. Gene targeting demonstrates additive detrimental effects of interleukin 1 and tumor necrosis factor during pancreatitis. Gastroenterology. 1997;113:1741–6. doi: 10.1053/gast.1997.v113.pm9352880. [DOI] [PubMed] [Google Scholar]
  • 74.Suzuki S, Miyasaka K, Jimi A, Funakoshi A. Induction of acute pancreatitis by cerulein in human IL-6 gene transgenic mice. Pancreas. 2000;21:86–92. doi: 10.1097/00006676-200007000-00056. [DOI] [PubMed] [Google Scholar]
  • 75.Gloor B, Todd KE, Lane JS, Rigberg DA, Reber HA. Mechanism of increased lung injury after acute pancreatitis in IL-10 knockout mice. J Surg Res. 1998;80:110–14. doi: 10.1006/jsre.1997.5289. [DOI] [PubMed] [Google Scholar]
  • 76.Gerard C, Frossard JL, Bhatia M, Saluja A, Gerard NP, Lu B, et al. Targeted disruption of the beta-chemokine receptor CCR1 protects against pancreatitis-associated lung injury. J Clin Invest. 1997;100:2022–7. doi: 10.1172/JCI119734. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Bhatia M, Saluja AK, Hofbauer B, Frossard JL, Lee HS, Castagliuolo I, et al. Role of substance P and the neurokinin 1 receptor in acute pancreatitis and pancreatitis-associated lung injury. Proc Natl Acad Sci U S A. 1998;95:4760–5. doi: 10.1073/pnas.95.8.4760. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Grady EF, Yoshimi SK, Maa J, Valeroso D, Vartanian RK, Rahim S, et al. Substance P mediates inflammatory oedema in acute pancreatitis via activation of the neurokinin-1 receptor in rats and mice. Br J Pharmacol. 2000;130:505–12. doi: 10.1038/sj.bjp.0703343. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Frossard JL, Saluja A, Bhagat L, Lee HS, Bhatia M, Hofbauer B, et al. The role of intercellular adhesion molecule 1 and neutrophils in acute pancreatitis and pancreatitis-associated lung injury. Gastroenterology. 1999;116:694–701. doi: 10.1016/s0016-5085(99)70192-7. [DOI] [PubMed] [Google Scholar]
  • 80.Kaufmann P, Tilz GP, Smolle KH, Demel U, Krejs GJ. Increased plasma concentrations of circulating intercellular adhesion molecule-1 (cICAM-1) in patients with necrotizing pancreatitis. Immunobiology. 1996;195:209–19. doi: 10.1016/S0171-2985(96)80040-4. [DOI] [PubMed] [Google Scholar]
  • 81.Werner J, Z'Graggen K, Fernandez-del Castillo C, Lewandrowski KB, Compton CC, Warshaw AL. Specific therapy for local and systemic complications of acute pancreatitis with monoclonal antibodies against ICAM-1. Ann Surg 1999;229:834–40; discussion 841–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Fu K, Tomita T, Sarras MP, Jr, De Lisle RC, Andrews GK. Metallothionein protects against cerulein-induced acute pancreatitis: analysis using transgenic mice. Pancreas. 1998;17:238–46. doi: 10.1097/00006676-199810000-00003. [DOI] [PubMed] [Google Scholar]
  • 83.Halangk W, Lerch MM, Brandt-Nedelev B, Roth W, Ruthenbuerger M, Reinheckel T, et al. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis. J Clin Invest. 2000;106:773–81. doi: 10.1172/JCI9411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Umans L, Serneels L, Overbergh L, Stas L, Van Leuven F. alpha2-macroglobulin- and murinoglobulin-1-deficient mice. A mouse model for acute pancreatitis. Am J Pathol. 1999;155:983–93. doi: 10.1016/s0002-9440(10)65198-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Bhatia M, Saluja AK, Singh VP, Frossard JL, Lee HS, Bhagat L, et al. Complement factor C5a exerts an anti-inflammatory effect in acute pancreatitis and associated lung injury. Am J Physiol Gastrointest Liver Physiol. 2001;280:G974–8. doi: 10.1152/ajpgi.2001.280.5.G974. [DOI] [PubMed] [Google Scholar]
  • 86.Merriam LT, Webster C, Joehl RJ. Complement component C5 deficiency reduces edema formation in murine ligation-induced acute pancreatitis. J Surg Res. 1997;67:40–5. doi: 10.1006/jsre.1996.4916. [DOI] [PubMed] [Google Scholar]
  • 87.Mizuma K, Schroder T, Kaarne M, Korpela H, Lempinen M. Serum phospholipase A2 in diet-induced pancreatitis. Eur Surg Res. 1984;16:156–61. doi: 10.1159/000128403. [DOI] [PubMed] [Google Scholar]
  • 88.Thal A, Brackney E. Acute hemorrhagic pancreatic necrosis produced by local Shwartzman reaction: experimental study on pancreatitis. JAMA. 1954;155:569–74. doi: 10.1001/jama.1954.73690240003011. [DOI] [PubMed] [Google Scholar]
  • 89.Thal A. Studies on pancreatitis. II. Acute pancreatic necrosis produced experimentally by the arthus sensitization reaction. Surgery. 1955;37:911–17. [PubMed] [Google Scholar]
  • 90.Janigan DT, Nevalainen TJ, MacAulay MA, Vethamany VG. Foreign serum-induced pancreatitis in mice. I. A new model of acute pancreatitis. Lab Invest. 1975;33:591–607. [PubMed] [Google Scholar]
  • 91.Nevalainen TJ, Fowlie FE, Janigan DT. Foreign serum-induced pancreatitis in mice. II. Secretory disturbances of acinar cells. Lab Invest. 1977;36:469–73. [PubMed] [Google Scholar]
  • 92.Nevalainen TJ. Pancreatic injury caused by intraductal injection of foreign serum in rat. Virchows Arch B Cell Pathol. 1978;27:89–98. doi: 10.1007/BF02888986. [DOI] [PubMed] [Google Scholar]
  • 93.Letko G, Mantke R, Sokolowski A, Spormann H. Enzymatic and histologic investigations into the course of pancreatic alterations induced by anti-acinar-cell-antiserum. Int Surg. 1990;75:254–8. [PubMed] [Google Scholar]
  • 94.Jancar S, De Giaccobi G, Mariano M, Mencia-Huerta JM, Sirois P, Braquet P. Immune complex induced pancreatitis: effect of BN 52021, a selective antagonist of platelet-activating factor. Prostaglandins. 1988;35:757–70. doi: 10.1016/0090-6980(88)90148-7. [DOI] [PubMed] [Google Scholar]
  • 95.Kanno H, Nose M, Itoh J, Taniguchi Y, Kyogoku M. Spontaneous development of pancreatitis in the MRL/Mp strain of mice in autoimmune mechanism. Clin Exp Immunol. 1992;89:68–73. doi: 10.1111/j.1365-2249.1992.tb06879.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Waldner H. Vascular mechanisms to induce acute pancreatitis. Eur Surg Res. 1992;24(Suppl 1):62–7. doi: 10.1159/000129240. [DOI] [PubMed] [Google Scholar]
  • 97.Banerjee AK, Galloway SW, Kingsnorth AN. Experimental models of acute pancreatitis. Br J Surg. 1994;81:1096–103. doi: 10.1002/bjs.1800810805. [DOI] [PubMed] [Google Scholar]
  • 98.Lombardi B, Estes LW, Longnecker DS. Acute hemorrhagic pancreatitis (massive necrosis) with fat necrosis induced in mice by DL-ethionine fed with a choline-deficient diet. Am J Pathol. 1975;79:465–80. [PMC free article] [PubMed] [Google Scholar]
  • 99.Lombardi B, Rao NK. Acute hemorrhagic pancreatic necrosis in mice. Influence of the age and sex of the animals and of dietary ethionine, choline, methionine, and adenine sulfate. Am J Pathol. 1975;81:87–99. [PMC free article] [PubMed] [Google Scholar]
  • 100.Gilliland L, Steer ML. Effects of ethionine on digestive enzyme synthesis and discharge by mouse pancreas. Am J Physiol. 1980;239:G418–26. doi: 10.1152/ajpgi.1980.239.5.G418. [DOI] [PubMed] [Google Scholar]
  • 101.Lombardi B. Influence of dietary factors on the pancreatotoxicity of ethionine. Am J Pathol. 1976;84:633–48. [PMC free article] [PubMed] [Google Scholar]
  • 102.Coelle EF, Adham N, Elashoff J, Lewin K, Taylor IL. Effects of prostaglandin and indomethacin on diet-induced acute pancreatitis in mice. Gastroenterology. 1983;85:1307–12. [PubMed] [Google Scholar]
  • 103.Buchler M, Friess H, Uhl W, Beger HG. Clinical relevance of experimental acute pancreatitis. Eur Surg Res. 1992;24(Suppl 1):85–8. doi: 10.1159/000129243. [DOI] [PubMed] [Google Scholar]
  • 104.Niederau C, Luthen R, Niederau MC, Grendell JH, Ferrell LD. Acute experimental hemorrhagic-necrotizing pancreatitis induced by feeding a choline-deficient, ethionine-supplemented diet. Methodology and standards. Eur Surg Res. 1992;24(Suppl 1):40–54. doi: 10.1159/000129238. [DOI] [PubMed] [Google Scholar]
  • 105.Rao KN, Eagon PK, Okamura K, Van Thiel DH, Gavaler JS, Kelly RH, et al. Acute hemorrhagic pancreatic necrosis in mice. Induction in male mice treated with estradiol. Am J Pathol. 1982;109:8–14. [PMC free article] [PubMed] [Google Scholar]
  • 106.Mizunuma T, Kawamura S, Kishino Y. Effects of injecting excess arginine on rat pancreas. J Nutr. 1984;114:467–71. doi: 10.1093/jn/114.3.467. [DOI] [PubMed] [Google Scholar]
  • 107.Hegyi P, Rakonczay Z, Jr, Sari R, Gog C, Lonovics J, Takacs T, et al. L-arginine-induced experimental pancreatitis. World J Gastroenterol. 2004;10:2003–9. doi: 10.3748/wjg.v10.i14.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Varga IS, Matkovics B, Hai DQ, Kotorman M, Takacs T, Sasvari M. Lipid peroxidation and antioxidant system changes in acute L-arginine pancreatitis in rats. Acta Physiol Hung. 1997;85:129–38. [PubMed] [Google Scholar]
  • 109.Czako L, Takacs T, Varga IS, Tiszlavicz L, Hai DQ, Hegyi P, et al. Involvement of oxygen-derived free radicals in L-arginine-induced acute pancreatitis. Dig Dis Sci. 1998;43:1770–7. doi: 10.1023/a:1018839821176. [DOI] [PubMed] [Google Scholar]
  • 110.Czako L, Takacs T, Varga IS, Tiszlavicz L, Hai DQ, Hegyi P, et al. Oxidative stress in distant organs and the effects of allopurinol during experimental acute pancreatitis. Int J Pancreatol. 2000;27:209–16. doi: 10.1385/IJGC:27:3:209. [DOI] [PubMed] [Google Scholar]
  • 111.Czako L, Takacs T, Varga IS, Hai DQ, Tiszlavicz L, Hegyi P, et al. The pathogenesis of L-arginine-induced acute necrotizing pancreatitis: inflammatory mediators and endogenous cholecystokinin. J Physiol Paris. 2000;94:43–50. doi: 10.1016/s0928-4257(99)00104-7. [DOI] [PubMed] [Google Scholar]
  • 112.Varga IS, Matkovics B, Czako L, Hai DQ, Kotorman M, Takacs T, et al. Oxidative stress changes in L-arginine-induced pancreatitis in rats. Pancreas. 1997;14:355–9. doi: 10.1097/00006676-199705000-00005. [DOI] [PubMed] [Google Scholar]
  • 113.Takacs T, Czako L, Morschl E, Laszlo F, Tiszlavicz L, Rakonczay Z, Jr, et al. The role of nitric oxide in edema formation in L-arginine-induced acute pancreatitis. Pancreas. 2002;25:277–82. doi: 10.1097/00006676-200210000-00010. [DOI] [PubMed] [Google Scholar]
  • 114.Takacs T, Czako L, Jarmay K, Farkas G, Jr, Mandi Y, Lonovics J. Cytokine level changes in L-arginine-induced acute pancreatitis in rat. Acta Physiol Hung. 1996;84:147–56. [PubMed] [Google Scholar]
  • 115.Rakonczay Z, Jr, Jarmay K, Kaszaki J, Mandi Y, Duda E, Hegyi P, et al. NF-kappaB activation is detrimental in arginine-induced acute pancreatitis. Free Radic Biol Med. 2003;34:696–709. doi: 10.1016/s0891-5849(02)01373-4. [DOI] [PubMed] [Google Scholar]
  • 116.Takacs T, Rakonczay Z, Jr, Varga IS, Ivanyi B, Mandi Y, Boros I, et al. Comparative effects of water immersion pretreatment on three different acute pancreatitis models in rats. Biochem Cell Biol. 2002;80:241–51. doi: 10.1139/o02-006. [DOI] [PubMed] [Google Scholar]
  • 117.Kishino Y, Kawamura S. Pancreatic damage induced by injecting a large dose of arginine. Virchows Arch B Cell Pathol Incl Mol Pathol. 1984;47:147–55. doi: 10.1007/BF02890197. [DOI] [PubMed] [Google Scholar]
  • 118.Tani S, Itoh H, Okabayashi Y, Nakamura T, Fujii M, Fujisawa T, et al. New model of acute necrotizing pancreatitis induced by excessive doses of arginine in rats. Dig Dis Sci. 1990;35:367–74. doi: 10.1007/BF01537416. [DOI] [PubMed] [Google Scholar]
  • 119.Weaver C, Bishop AE, Polak JM. Pancreatic changes elicited by chronic administration of excess L-arginine. Exp Mol Pathol. 1994;60:71–87. doi: 10.1006/exmp.1994.1007. [DOI] [PubMed] [Google Scholar]
  • 120.Delaney CP, McGeeney KF, Dervan P, Fitzpatrick JM. Pancreatic atrophy: a new model using serial intra-peritoneal injections of L-arginine. Scand J Gastroenterol. 1993;28:1086–90. doi: 10.3109/00365529309098314. [DOI] [PubMed] [Google Scholar]
  • 121.Steinberg W, Tenner S. Acute pancreatitis. N Engl J Med. 1994;330:1198–210. doi: 10.1056/NEJM199404283301706. [DOI] [PubMed] [Google Scholar]
  • 122.Renner IG, Savage WT, 3rd, Pantoja JL, Renner VJ. Death due to acute pancreatitis. A retrospective analysis of 405 autopsy cases. Dig Dis Sci. 1985;30:1005–18. doi: 10.1007/BF01308298. [DOI] [PubMed] [Google Scholar]
  • 123.Karimgani I, Porter KA, Langevin RE, Banks PA. Prognostic factors in sterile pancreatic necrosis. Gastroenterology. 1992;103:1636–40. doi: 10.1016/0016-5085(92)91189-b. [DOI] [PubMed] [Google Scholar]
  • 124.Pfeffer RB, Stasior O, Hinton JW. The clinical picture of the sequential development of acute hemorrhagic pancreatitis in the dog. Surg Forum. 1957;8:248–51. [PubMed] [Google Scholar]
  • 125.Byrne JJ, Joison J. Bacterial regurgitation in experimental pancreatitis. Am J Surg. 1964;107:317–20. doi: 10.1016/0002-9610(64)90274-0. [DOI] [PubMed] [Google Scholar]
  • 126.Nance FC, Cain JL. Studies of hemorrhagic pancreatitis in germ-free dogs. Gastroenterology. 1968;55:368–74. [PubMed] [Google Scholar]
  • 127.Johnson RH, Doppman J. Duodenal reflux and the etiology of pancreatitis. Surgery. 1967;62:462–7. [PubMed] [Google Scholar]
  • 128.Nevalainen TJ, Seppa A. Acute pancreatitis caused by closed duodenal loop in the rat. Scand J Gastroenterol. 1975;10:521–7. [PubMed] [Google Scholar]
  • 129.Chetty U, Gilmour HM, Taylor TV. Experimental acute pancreatitis in the rat – a new model. Gut. 1980;21:115–17. doi: 10.1136/gut.21.2.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 130.Ferrie MM, O'Hare R, Joffe SN. Acute and chronic pancreatitis in the rat caused by a closed duodenal loop. Digestion. 1978;18:280–5. doi: 10.1159/000198211. [DOI] [PubMed] [Google Scholar]
  • 131.Orda R, Hadas N, Orda S, Wiznitzer T. Experimental acute pancreatitis. Inducement by taurocholate sodium-trypsin injection into a temporarily closed duodenal loop in the rat. Arch Surg. 1980;115:327–9. doi: 10.1001/archsurg.1980.01380030073018. [DOI] [PubMed] [Google Scholar]
  • 132.Murakami H, Togawa M, Takahashi S, Kasahara N, Yamamoto J, Matsuura N, et al. Pharmacological studies of 6-amidino-2-naphthyl 4-[(4,5-dihydro-1H-imidazol-2-yl)amino]benzoate dimethanesulfonate. Effects on experimental pancreatitis. Arzneimittelforschung. 1990;40:1352–8. [PubMed] [Google Scholar]
  • 133.Kagugawa Y, Takeda K, Sunamura M, Kawaguchi S, Kobari M, Matsuno S. Effect of continuous arterial infusion of protease inhibitor on experimental acute pancreatitis induced by closed duodenal loop obstruction. Nippon Shokakibyo Gakkai Zasshi. 1990;87:1444–50. [PubMed] [Google Scholar]
  • 134.Ono H, Hayakawa T, Kondo T, Shibata T, Kitagawa M, Sakai Y, et al. Prevention of experimental acute pancreatitis by intraduodenal trypsin inhibitor in rat. Dig Dis Sci. 1990;35:787–92. doi: 10.1007/BF01540185. [DOI] [PubMed] [Google Scholar]
  • 135.Ohnishi H, Kosuzume H, Ashida Y, Kato K, Honjo I. Effects of urinary trypsin inhibitor on pancreatic enzymes and experimental acute pancreatitis. Dig Dis Sci. 1984;29:26–32. doi: 10.1007/BF01296858. [DOI] [PubMed] [Google Scholar]
  • 136.Takasugi S, Yonezawa H, Ikei N, Kanno T. Prevention of acute experimental pancreatitis in rats and dogs by intraduodenal infusion of a synthetic trypsin inhibitor. Digestion. 1982;24:36–41. doi: 10.1159/000198772. [DOI] [PubMed] [Google Scholar]
  • 137.De Rai P, Franciosi C, Confalonieri GM, Biffi R, Andreoni B, Uggeri F, et al. Effects of somatostatin on acute pancreatitis induced in rats by injection of taurocholate and trypsin into a temporarily closed duodenal loop. Int J Pancreatol. 1988;3:367–73. doi: 10.1007/BF02788470. [DOI] [PubMed] [Google Scholar]
  • 138.Crocket KV, Brackett K, Crocket A, Jacobson ED, Rao SS, Joffe SN. Prostaglandin E1 treatment in experimental acute pancreatitis in the rat. Eur Surg Res. 1984;16:265–73. doi: 10.1159/000128418. [DOI] [PubMed] [Google Scholar]
  • 139.Schapiro H, McDougal HD, Morrison EJ, Wan AT. Acute hemorrhagic pancreatitis in the dog. IV. Treatment with vasopressin. Am J Dig Dis. 1976;21:286–9. doi: 10.1007/BF01071840. [DOI] [PubMed] [Google Scholar]
  • 140.Crocket KV, Reising JR, Wirman JA, Gau N, Joffe SN. Effect of Dextran 40 and aprotinin on experimental acute pancreatitis. J Surg Res. 1984;36:256–64. doi: 10.1016/0022-4804(84)90096-9. [DOI] [PubMed] [Google Scholar]
  • 141.Weber A, Friess H, Sill U, Buchler M. The closed duodenal loop technique. Eur Surg Res. 1992;24(Suppl 1):24–8. doi: 10.1159/000129236. [DOI] [PubMed] [Google Scholar]
  • 142.Farmer RC, Maslin SC, Reber HA. Acute pancreatitis: the role of duct permeability. Surg Forum. 1983;34:224–7. [Google Scholar]
  • 143.Wedgwood KR, Farmer RC, Reber HA. A model of hemorrhagic pancreatitis in cats – role of 16,16-dimethyl prostaglandin E2. Gastroenterology. 1986;90:32–9. doi: 10.1016/0016-5085(86)90071-5. [DOI] [PubMed] [Google Scholar]
  • 144.Widdison AL, Alvarez C, Reber HA. The low-pressure duct perfusion model of acute pancreatitis. Eur Surg Res. 1992;24(Suppl 1):55–61. doi: 10.1159/000129239. [DOI] [PubMed] [Google Scholar]
  • 145.Olazabal A. Effect of prostaglandins E2 and I2 and of indomethacin on deoxycholic acid-induced damage to the rat bile-pancreatic duct. Gastroenterology. 1983;84((5 Pt 1)):928–34. [PubMed] [Google Scholar]
  • 146.Bilchik AJ, Leach SD, Zucker KA, Modlin IM. Experimental models of acute pancreatitis. J Surg Res. 1990;48:639–47. doi: 10.1016/0022-4804(90)90245-w. [DOI] [PubMed] [Google Scholar]
  • 147.Aho HJ, Koskensalo SM, Nevalainen TJ. Experimental pancreatitis in the rat. Sodium taurocholate-induced acute haemorrhagic pancreatitis. Scand J Gastroenterol. 1980;15:411–16. doi: 10.3109/00365528009181493. [DOI] [PubMed] [Google Scholar]
  • 148.Beck IT, Kahn DS, Solymar J, McKenna RD, Zylberszac B. The role of pancreatic enzymes in the pathogenesis of acute pancreatitis. III. Comparison of the pathologic and biochemical changes in the canine pancreas to intraductal injection with bile and with trypsin. Gastroenterology. 1964;46:531–42. [PubMed] [Google Scholar]
  • 149.Opie EL. The etiology of acute hemorrhagic pancreatitis. Johns Hopkins Hosp Bull. 1901;12:182–90. [Google Scholar]
  • 150.Papp M, Makara GB, Hajtman B, Csaki L. A quantitative study of pancreatic blood flow in experimental pancreatitis. Gastroenterology. 1966;51:524–8. [PubMed] [Google Scholar]
  • 151.Sum PT, Bencosme SA, Beck IT. Pathogenesis of bile-induced acute pancreatitis in the dog. Experiments with detergents. Am J Dig Dis. 1970;15:637–46. doi: 10.1007/BF02236023. [DOI] [PubMed] [Google Scholar]
  • 152.Musa BE, Nelson AW, Gillette EL, Ferguson HL, Lumb WV. A model to study acute pancreatitis in the dog. J Surg Res. 1976;21:51–6. doi: 10.1016/0022-4804(76)90009-3. [DOI] [PubMed] [Google Scholar]
  • 153.Aho HJ, Nevalainen TJ. Experimental pancreatitis in the rat. Ultrastructure of sodium taurocholate-induced pancreatic lesions. Scand J Gastroenterol. 1980;15:417–24. doi: 10.3109/00365528009181494. [DOI] [PubMed] [Google Scholar]
  • 154.Aho HJ, Nevalainen TJ, Aho AJ. Experimental pancreatitis in the rat. Development of pancreatic necrosis, ischemia and edema after intraductal sodium taurocholate injection. Eur Surg Res. 1983;15:28–36. doi: 10.1159/000128330. [DOI] [PubMed] [Google Scholar]
  • 155.Schmidt J, Rattner DW, Lewandrowski K, Compton CC, Mandavilli U, Knoefel WT, et al. A better model of acute pancreatitis for evaluating therapy. Ann Surg. 1992;215:44–56. doi: 10.1097/00000658-199201000-00007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 156.Hietaranta AJ, Aho HJ, Gronroos JM, Hua ZY, Nevalainen TJ. Pancreatic phospholipase A2 in proximal tubules of rat kidney in experimental acute pancreatitis and after intravenous injection of the enzyme. Pancreas. 1992;7:326–33. doi: 10.1097/00006676-199205000-00009. [DOI] [PubMed] [Google Scholar]
  • 157.Elliott DW, Williams RD, Zollinger RM. Alterations in the pancreatic resistance to bile in the pathogenesis of acute pancreatitis. Ann Surg 1957;146:669–81; discussion 681–2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 158.Arendt T. Bile-induced acute pancreatitis in cats. Roles of bile, bacteria, and pancreatic duct pressure. Dig Dis Sci. 1993;38:39–44. doi: 10.1007/BF01296771. [DOI] [PubMed] [Google Scholar]
  • 159.Condon RE, Woods JH, Poulin TL, Wagner WG, Pissiotis CA. Experimental pancreatitis treated with glucagon or lactated Ringer solution. Arch Surg. 1974;109:154–8. doi: 10.1001/archsurg.1974.01360020016004. [DOI] [PubMed] [Google Scholar]
  • 160.Bockman DE, Schiller WR, Anderson MC. Route of retrograde flow in the exocrine pancreas during ductal hypertension. Arch Surg. 1971;103:321–9. doi: 10.1001/archsurg.1971.01350080237038. [DOI] [PubMed] [Google Scholar]
  • 161.Klar E, Messmer K, Warshaw AL, Herfarth C. Pancreatic ischaemia in experimental acute pancreatitis: mechanism, significance and therapy. Br J Surg. 1990;77:1205–10. doi: 10.1002/bjs.1800771104. [DOI] [PubMed] [Google Scholar]
  • 162.Beger HG, Rau B, Mayer J, Pralle U. Natural course of acute pancreatitis. World J Surg. 1997;21:130–5. doi: 10.1007/s002689900204. [DOI] [PubMed] [Google Scholar]
  • 163.Bassi D, Kollias N, Fernandez-del Castillo C, Foitzik T, Warshaw AL, Rattner DW. Impairment of pancreatic microcirculation correlates with the severity of acute experimental pancreatitis. J Am Coll Surg. 1994;179:257–63. [PubMed] [Google Scholar]
  • 164.Gullo A, Berlot G. Ingredients of organ dysfunction or failure. World J Surg. 1996;20:430–6. doi: 10.1007/s002689900068. [DOI] [PubMed] [Google Scholar]
  • 165.Pfeffer RB, Lazzarini-Robertson A, Jr, Safadi D, Mixter G, Jr, Secoy CF, Hinton JW. Gradations of pancreatitis, edematous, through hemorrhagic, experimentally produced by controlled injection of microspheres into blood vessels in dogs. Surgery. 1962;51:764–9. [PubMed] [Google Scholar]
  • 166.Lefer AM, Spath JA., Jr Pancreatic hypoperfusion and the production of a myocardial depressant factor in hemorrhagic shock. Ann Surg. 1974;179:868–76. doi: 10.1097/00000658-197406000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 167.Barzilai A, Ryback BJ, Medina JA, Toth L, Dreiling DA. The morphological changes of the pancreas in hypovolemic shock and the effect of pretreatment with steroids. Int J Pancreatol. 1987;2:23–32. doi: 10.1007/BF02788346. [DOI] [PubMed] [Google Scholar]
  • 168.Warshaw AL, O'Hara PJ. Susceptibility of the pancreas to ischemic injury in shock. Ann Surg. 1978;188:197–201. doi: 10.1097/00000658-197808000-00012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 169.Eibl G, Buhr HJ, Foitzik T. Therapy of microcirculatory disorders in severe acute pancreatitis: what mediators should we block? Intensive Care Med. 2002;28:139–46. doi: 10.1007/s00134-001-1194-1. [DOI] [PubMed] [Google Scholar]
  • 170.Spormann H, Sokolowski A, Birkigt HG, Letko G. Contribution of pancreatic edema and short-term ischemia to experimental acute pancreatitis in the rat. I. Procedure and pathomorphological investigations. Z Exp Chir Transplant Kunstliche Organe. 1986;19:323–30. [PubMed] [Google Scholar]
  • 171.Redha F, Uhlschmid G, Ammann RW, Freiburghaus AU. Injection of microspheres into pancreatic arteries causes acute hemorrhagic pancreatitis in the rat: a new animal model. Pancreas. 1990;5:188–93. doi: 10.1097/00006676-199003000-00011. [DOI] [PubMed] [Google Scholar]
  • 172.Sjovall S, Holmin T, Evander A, Stenram U. Splenic and gastro-duodenal vein occlusion – influence on the pancreatic gland and on the outcome of experimental pancreatitis. Int J Pancreatol. 1988;3:143–9. doi: 10.1007/BF02798925. [DOI] [PubMed] [Google Scholar]
  • 173.Shibayama Y. Pancreatic venous stasis and endotoxaemia as aetiologic factors in acute haemorrhagic pancreatitis. J Pathol. 1987;152:177–82. doi: 10.1002/path.1711520306. [DOI] [PubMed] [Google Scholar]
  • 174.Freiburghaus AU, Redha F, Ammann RW. Acute pancreatitis after microembolism of the rat pancreas progresses into chronic pancreatitis. Digestion 1993;54:277.(abstract). [Google Scholar]
  • 175.Fernandez-del Castillo C, Harringer W, Warshaw AL, Vlahakes GJ, Koski G, Zaslavsky AM, et al. Risk factors for pancreatic cellular injury after cardiopulmonary bypass. N Engl J Med. 1991;325:382–7. doi: 10.1056/NEJM199108083250602. [DOI] [PubMed] [Google Scholar]
  • 176.Fernandez-Cruz L, Sabater L, Gilabert R, Ricart MJ, Saenz A, Astudillo E. Native and graft pancreatitis following combined pancreas-renal transplantation. Br J Surg. 1993;80:1429–32. doi: 10.1002/bjs.1800801125. [DOI] [PubMed] [Google Scholar]
  • 177.Takahasi TYN. Ischemic injury of the human pancreas. Its basic patterns correlated with the pancreatic microvasculature. Pathol Res Pract. 1985;179:645–51. doi: 10.1016/S0344-0338(85)80211-9. [DOI] [PubMed] [Google Scholar]
  • 178.Menger MD, Vollmar B, Glasz J, Post S, Messmer K. Microcirculatory manifestations of hepatic ischemia/reperfusion injury. Prog Appl Microcirc. 1993;19:106–24. [Google Scholar]
  • 179.Hoffmann TF, Leiderer R, Waldner H, Arbogast S, Messmer K. Ischemia reperfusion of the pancreas: a new in vivo model for acute pancreatitis in rats. Res Exp Med (Berl) 1995;195:125–44. doi: 10.1007/BF02576782. [DOI] [PubMed] [Google Scholar]
  • 180.Broe PJ, Zuidema GD, Cameron JL. The role of ischemia in acute pancreatitis: studies with an isolated perfused canine pancreas. Surgery. 1982;91:377–82. [PubMed] [Google Scholar]
  • 181.Gress TM, Arnold R, Adler G. Structural alterations of pancreatic microvasculature in cerulein-induced pancreatitis in the rat. Res Exp Med (Berl) 1990;190:401–12. doi: 10.1007/BF00000046. [DOI] [PubMed] [Google Scholar]
  • 182.Busing M, Hopt UT, Schareck WD, Quacken M, Morgenroth K. Ultrastructural changes of human pancreatic allografts after cold ischemia and reperfusion. Transplant Proc. 1990;22:612–13. [PubMed] [Google Scholar]
  • 183.Busing M, Hopt UT, Quacken M, Becker HD, Morgenroth K. Morphological studies of graft pancreatitis following pancreas transplantation. Br J Surg. 1993;80:1170–3. doi: 10.1002/bjs.1800800935. [DOI] [PubMed] [Google Scholar]
  • 184.Anderson MC, Schiller WR. Microcirculatory dynamics in the normal and inflamed pancreas. Am J Surg. 1968;115:118–27. doi: 10.1016/0002-9610(68)90139-6. [DOI] [PubMed] [Google Scholar]
  • 185.Becker H, Vinten-Johansen J, Buckberg GD, Bugyi HI. Correlation of pancreatic blood flow and high-energy phosphates during experimental pancreatitis. Eur Surg Res. 1982;14:203–10. doi: 10.1159/000128290. [DOI] [PubMed] [Google Scholar]
  • 186.Kelly DM, McEntee GP, McGeeney KF, Fitzpatrick JM. Microvasculature of the pancreas, liver, and kidney in cerulein-induced pancreatitis. Arch Surg. 1993;128:293–5. doi: 10.1001/archsurg.1993.01420150049009. [DOI] [PubMed] [Google Scholar]
  • 187.Baxter JN, Jenkins SA, Day DW, Roberts NB, Cowell DC, Mackie CR, et al. Effects of somatostatin and a long-acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat. Br J Surg. 1985;72:382–5. doi: 10.1002/bjs.1800720516. [DOI] [PubMed] [Google Scholar]
  • 188.Walker NI. Ultrastructure of the rat pancreas after experimental duct ligation. I. The role of apoptosis and intraepithelial macrophages in acinar cell deletion. Am J Pathol. 1987;126:439–51. [PMC free article] [PubMed] [Google Scholar]
  • 189.Lerch MM, Adler G. Experimental animal models of acute pancreatitis. Int J Pancreatol. 1994;15:159–70. [PubMed] [Google Scholar]
  • 190.Lerch M, Adler G. Experimental pancreatitis. Current opinion in gastroenterology. 1993;9:752–9. [Google Scholar]
  • 191.Vasilescu C, Tasca C. Acute experimental pancreatitis – morphological evidence for the development of a multiple organ failure syndrome. Rom J Morphol Embryol. 1991;37:25–9. [PubMed] [Google Scholar]
  • 192.Popper HL, Necheles H. Edema of the pancreas. Surg Gynecol Obstet. 1942;74:123. [Google Scholar]
  • 193.Popper HL, Necheles H, Russell KC. Transition of pancreatic edema into pancreatic necrosis. Surg Gynecol Obstet. 1948;87:79. [PubMed] [Google Scholar]
  • 194.Lerch MM, Saluja AK, Dawra R, Ramarao P, Saluja M, Steer ML. Acute necrotizing pancreatitis in the opossum: earliest morphological changes involve acinar cells. Gastroenterology. 1992;103:205–13. doi: 10.1016/0016-5085(92)91114-j. [DOI] [PubMed] [Google Scholar]
  • 195.Lerch MM, Saluja AK, Runzi M, Dawra R, Saluja M, Steer ML. Pancreatic duct obstruction triggers acute necrotizing pancreatitis in the opossum. Gastroenterology. 1993;104:853–61. doi: 10.1016/0016-5085(93)91022-a. [DOI] [PubMed] [Google Scholar]
  • 196.Cavuoti OP, Moody FG, Martinez G. Role of pancreatic duct occlusion with prolamine (Ethibloc) in necrotizing pancreatitis. Surgery. 1988;103:361–6. [PubMed] [Google Scholar]
  • 197.Senninger N, Moody FG, Coelho JC, Van Buren DH. The role of biliary obstruction in the pathogenesis of acute pancreatitis in the opossum. Surgery. 1986;99:688–93. [PubMed] [Google Scholar]
  • 198.Acosta JM, Ledesma CL. Gallstone migration as a cause of acute pancreatitis. N Engl J Med. 1974;290:484–7. doi: 10.1056/NEJM197402282900904. [DOI] [PubMed] [Google Scholar]
  • 199.Gukovskaya AS, Perkins P, Zaninovic V, Sandoval D, Rutherford R, Fitzsimmons T, et al. Mechanisms of cell death after pancreatic duct obstruction in the opossum and the rat. Gastroenterology. 1996;110:875–84. doi: 10.1053/gast.1996.v110.pm8608898. [DOI] [PubMed] [Google Scholar]
  • 200.Chen JW, Saccone GT, Toouli J. Sphincter of Oddi dysfunction and acute pancreatitis. Gut. 1998;43:305–8. doi: 10.1136/gut.43.3.305. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 201.Chen JW, Thomas A, Woods CM, Schloithe AC, Toouli J, Saccone GT. Sphincter of Oddi dysfunction produces acute pancreatitis in the possum. Gut. 2000;47:539–45. doi: 10.1136/gut.47.4.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 202.Liu YF, Saccone GT, Thune A, Baker RA, Harvey JR, Toouli J. Sphincter of Oddi regulates flow by acting as a variable resistor to flow. Am J Physiol. 1992;263((5 Pt 1)):G683–9. doi: 10.1152/ajpgi.1992.263.5.G683. [DOI] [PubMed] [Google Scholar]
  • 203.Toouli J, Baker RA. Innervation of the sphincter of Oddi: physiology and considerations of pharmacological intervention in biliary dyskinesia. Pharmacol Ther. 1991;49:269–81. doi: 10.1016/0163-7258(91)90058-t. [DOI] [PubMed] [Google Scholar]

Articles from HPB : The Official Journal of the International Hepato Pancreato Biliary Association are provided here courtesy of Elsevier

RESOURCES